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ABSTRACT 
 
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting 
birds in the southeastern United States.  The cause of the disease has not yet been 
determined but is believed to be a naturally produced toxin and is associated with 
aquatic vegetation.  Current research on AVM is limited to in vivo studies 
utilizing whole tissue or vegetative samples.  The objectives of this research were 
to develop extraction methods for isolating the putative AVM toxin from 
vegetative samples and to develop an in vitro bioassay for detection and study of 
the toxin.   Samples of vegetation were collected from reservoirs known to be 
affected by AVM and confirmed to contain the toxin by mallard bioassay.  The 
collected vegetation was then extracted with a series of solvents and the crude 
extracts were re-introduced to a mallard model to confirm the presence or absence 
of the AVM agent.  All birds administered a methanol extract developed 
characteristic AVM lesions, indicating that methanol is a suitable solvent for 
AVM toxin extraction. Additional crude extracts were produced from vegetation 
collected at AVM-affected reservoirs as well as reservoirs with no known history 
of AVM and evaluated for their in vitro toxicity using established cell lines.  
Extracts produced from vegetation collected at AVM sites induced a significant 
cell cycle arrest in C6 glioma cells, while AVM-negative extracts induced only 
mild effects on this endpoint.  To further evaluate this in vitro assay for its ability 
to detect the AVM toxin, as well as continue the development of toxin extraction 
iv 
methods, fractions were produced from a crude methanol extract and evaluated 
for toxicity by the cell cycle assay as well as an in vivo chicken bioassay.  The 
fractionation methods were successful in isolating the in vitro toxicity, but the 
presence of the AVM toxin could not be confirmed in these fractions due to 
inconclusive in vivo results. Further testing will be necessary to determine if the 
observed cell cycle arrest is due to the etiologic agent of AVM as well as to 
advance the process of AVM toxin isolation and characterization, but this 
research has providing promising tools for future AVM investigations. 
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PREFACE 
 
This dissertation was written in journal style and organized into five 
chapters, preceded by a general introduction and followed by a conclusions 
section.  The chapters represent different research projects and each is comprised 
of introduction, materials and methods, results, discussion, and literature cited 
sections.  Each chapter is intended for separate publication; therefore, repetition is 
present in some sections. 

INTRODUCTION 
 
Avian vacuolar myelinopathy (AVM) is a neurological disease primarily 
affecting bald eagles (Haliaeetus leucocephalus) and American coots (Fulica 
americana) in the southeastern U.S.  AVM was first observed during the winter of 
1994-1995 and has been documented in five states: Arkansas, Georgia, North 
Carolina, South Carolina, and Texas. Since 1994, AVM has been responsible for 
the deaths of over 100 bald eagles and estimates of over a thousand coots. Despite 
extensive investigations, the cause of AVM remains unknown, though all 
information gathered to date suggests a toxin, most likely of natural origin. 
 AVM is characterized and diagnosed by a spongy degeneration of the 
white matter of the central nervous system (CNS). Multiple vacuoles of varying 
severity are seen throughout the white matter of the brain and spinal cord, being 
particularly prominent in the optic tectum (Thomas et al., 1998). Birds with AVM 
may display clinical signs of neurological impairment, including difficulty in 
swimming, flying, and/or walking. Not all birds with AVM lesions display these 
signs, and clinical recovery has been documented despite the persistence of 
lesions (Larsen et al., 2002).  
 The first documented cases of AVM occurred during the winter of 1994-
1995 at DeGray Lake, Arkansas, USA (Thomas et al., 1998). During this event, 
29 bald eagles were found either dead or dying, and those still alive displayed 
signs of neurological impairment. Two winters later, 26 eagles died at DeGray 
Lake and nearby Lakes Ouachita and Hamilton. Wintering American coots were
4observed with similar signs of impairment during both of these events, though 
only a small number were found dead.  Thorough diagnostic evaluations of eagles 
and coots were conducted by the National Wildlife Health Center, Madison, 
Wisconsin, USA.  No consistent gross abnormalities were seen and no infectious 
disease agents were discovered.  In addition, no significant concentrations of any 
toxins or toxicants were detected.  The only consistent finding was the presence of 
microscopic vacuoles throughout the white matter of the CNS.  Electron 
microscopy confirmed the vacuoles were formed by separation of the myelin 
lamellae at the intraperiod line, a condition known as intramyelinic edema 
(Thomas et al., 1998). This condition can be caused by several known chemicals, 
including triethyltin, hexachlorophene, bromethalin, and others, though none of 
these compounds were detected in tissues.   
 AVM was first documented outside of Arkansas during the winter of 
1997-1998, when affected coots were observed at Woodlake (Lake Surf), North 
Carolina and Lake Juliette, Georgia. The following winter, additional affected 
coots were observed at these sites, as well as at Lake Ouachita, Arkansas and 
three sites in South Carolina: Lake Murray, J. Strom Thurmond Lake (JSTL), and 
Par Pond, a reservoir at the Savannah River Site (SRS).  In addition, Lake Juliette, 
Woodlake, JSTL, and SRS each had one eagle mortality. AVM was first 
documented in waterfowl during the winter of 1998-1999, with a low incidence of 
AVM in mallards (Anas platyrhynchos), ring-necked ducks (Aythya collari), and 
buffleheads (Bucephala albeola) at Woodlake (Augspurger et al., 2003). The 
largest eagle mortality events outside of Arkansas occurred at JSTL during the 
5winters of 2000-2001 and 2001-2002, during which 23 eagles died. Several more 
species have also been documented with AVM, including Canada geese (Branta 
canadensis), great-horned owl (Bubo virginianus), and killdeer (Charadrius 
vociferus) (Fischer et al., 2002).  
 In recent years, eagle mortalities continue to be observed and AVM-
positive coots are observed each year at sites where active monitoring is 
conducted (Fischer et al., 2006).  In addition, several more sites of AVM 
mortalities have been documented in recent years, including several small 
residential ponds in Georgia and North Carolina, and a small farm pond in South 
Carolina (Wilde et al., 2005; Fischer, unpubl. data). These sites demonstrate that 
AVM is not restricted to large reservoirs and may be undetected in smaller 
systems. 
 While the cause of AVM remains elusive, evidence gathered to date 
suggests a toxin of natural origin. The lack of inflammatory response in tissues 
and inability to detect any infectious disease agents makes the probability of a 
bacterial or viral infection very low.  In addition, the disease has not been shown 
to be transmissible by direct contact with affected birds (Larsen et al., 2003). The 
pathology of AVM suggests an acutely toxic compound, since the lesions 
manifest quickly without any systemic involvement (Thomas et al., 1998).  The 
nature of AVM epornitics also indicates a toxin as the source of disease.  Rocke et 
al. (2002) conducted a sentinel study in which healthy coots and mallards were 
released over a four-year period onto Woodlake.  Results showed that AVM is 
site-specific, can have a quick time of onset (as early as 5 days post-release), and 
6is seasonal, with AVM events occurring during the late fall to early winter and 
lasting up to several months.   
 The search for the toxic agent has proven challenging. As mentioned, 
extensive toxicological tests were conducted on coot and eagle tissues during the 
first AVM epizootics (Thomas et al., 1998). Various tissues were analyzed for a 
wide spectrum of organic and inorganic compounds, but no significant 
concentrations were detected.  In a separate study, coot tissues and sediments 
from AVM reservoirs and control sites were analyzed for lipophilic organic 
compounds in hopes of finding a compound unique to AVM sites (Dodder et al., 
2003).  Despite the presence of detectable contaminants, no compound could be 
singled out as a probable suspect. 
 Although the causative agent has not yet been discovered, it is now 
evident that AVM is acquired orally, through consumption of affected food items. 
In the first study to reproduce AVM in the laboratory, Fischer et al. (2003) 
demonstrated transmission from AVM-affected coot tissue to red-tailed hawks 
(Buteo jamaicensis), establishing the link between coots and eagles in the wild. 
During coot migrations, which generally coincide with AVM epornitics, these 
water birds are a major food source for bald eagles.  
 With evidence that AVM is acquired by ingestion, the food sources of 
coots in these reservoirs became a focus of research.  All known AVM reservoirs 
contain one or more of the exotic aquatic plants hydrilla (Hydrilla verticillata), 
Brazilian elodea (Egeria densa), or Eurasian watermilfoil (Myriophyllum 
spicatum). These species cover extensive acreage in the reservoirs and serve as 
7the major food item of wintering coots. The first study to attempt induction of 
AVM in waterfowl through ingestion of this aquatic vegetation was unsuccessful. 
In that study, mallards were orally gavaged with hydrilla from an AVM reservoir 
for seven days (Larsen et al., 2003).  Sediment and water from the same reservoir 
were also examined as potential sources.  No mallards developed lesions, though 
the authors suggest that exposure duration and quantity of material consumed may 
have been inadequate to induce the disease, or the vegetation could have been 
collected at a time when the AVM agent was not present.  
 Three independent studies have now confirmed that coots and waterfowl 
do acquire AVM though ingestion of aquatic vegetation. These studies induced 
AVM in mallards and domestic chickens (Gallus domesticus) by ingestion of 
hydrilla and associated materials collected from JSTL during an AVM epizootic 
(Birrenkott, 2003; Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et al. 
2005). The studies allowed the birds to feed ad libitum, with exposures ranging 
from 23 days to seven weeks. Hydrilla does not appear to be the causative agent 
of AVM, as it does not occur at all AVM sites and it is found in other areas where 
AVM has not been documented.  It is thought, rather, that something associated 
with aquatic vegetation may be the cause. 
 Hydrilla collected from JSTL that induced AVM in the mallard laboratory 
study (Birrenkott et al., 2004) contained large quantities of a novel cyanobacteria 
species.  Colonies of this species, a previously uncharacterized member of the 
Order Stigonematales (Williams et al., 2007), covered 50-90% of the leaf surface 
of the hydrilla (Birrenkott et al., 2004).  Surveys of cyanobacterial epiphytes 
8revealed the consistent presence of this Stigonematalan species at all known sites 
of AVM epizootics (Wilde et al., 2005). The species was also found at a few sites 
where AVM has not been documented, though the relative abundance at these 
sites was significantly less than sites of AVM epornitics (Wilde et al., 2005). 
Researchers have postulated that this species produces a toxin responsible for 
AVM.  The novel Stigonematalan species has been successfully cultured in the 
laboratory and genetic and physiological analyses have begun (Habrun, 2004). A 
preliminary feeding trial in which Stigonematalan cultures were fed by gavage to 
American coots produced no definitive lesions in the treatment birds (Wilde, 
unpubl. data).  This does not disprove the hypothesis that the cyanobacteria are 
the producer of the toxin.  The cyanobacterial cultures may not have been actively 
producing the toxin at the time of feeding, or the birds may not have been exposed 
to sufficient concentrations for the disease to develop. Cultures of the 
cyanobacteria are currently being grown under differing nutrient and temperature 
regimes, and these cultures will be used in future feeding trials.  
Much research is still needed in the study of AVM, in addition to 
determining the cause and source of the disease. The pathology, range of 
susceptible species, implications for wildlife populations, and management 
strategies all need to be further explored.  Areas of potential research on the 
pathology of AVM include mechanism of action, exposure time and concentration 
necessary to produce the disease, possibility of recovery, and acute versus chronic 
exposure effects. It is unknown why some birds develop clinical neurological 
signs and others do not. Clinical recovery has been shown in coots after being 
9taken into captivity, though lesions were still present upon necropsy 65 days later 
(Larsen et al., 2002).  It is unknown whether or not the lesions can heal.  In 
addition, there have been several reports of birds displaying clinical signs 
consistent with AVM without the presence of lesions upon necropsy (Lewis-Weis 
et al., 2004; Rocke et al., 2005). 
 The list of species known to be susceptible to AVM is currently confined 
to birds, but susceptibility of other classes of organisms should be further 
explored. Lesions have never been confirmed in mammals during AVM 
epizootics, though there has been anecdotal evidence of possible clinical signs in 
a beaver (Castor canadensis) (Lewis-Weis et al., 2004).  Histological analysis of 
brains from beavers, raccoons (Procyon lotor), and a gray fox (Urocyon 
cinereoargenteus) collected at J. Strom Thurmond Lake revealed no 
abnormalities, despite the presence of coot tissues in the intestinal contents of one 
raccoon and the fox (Fischer et al., 2006).  Swine failed to develop lesions when 
fed AVM-affected coot tissue in a laboratory study, though the authors 
acknowledge that the duration of exposure and quantity of ingested material 
should be explored further before concluding that mammals are not susceptible 
(Lewis-Weis et al., 2004).  Mice fed hydrilla collected during AVM events also 
failed to develop lesions (Rocke et al., 2005; Birrenkott, unpubl. data); however, 
these animals did not appear to consume much, if any, of the vegetation in one 
study (Birrenkott, unpubl. data). It is also possible that the vegetation did not 
contain the causative agent in sufficient quantity to induce disease.  
10 
 The impact of AVM to wildlife populations is largely unknown. 
Birrenkott (2003) examined the impact of AVM on South Carolina and Georgia’s 
bald eagle population, concluding that AVM has significantly affected local 
populations. Since eagles in these states are non-migratory and their breeding 
seasons coincide with AVM epizootics, AVM could pose a significant risk to 
statewide populations if it should spread to other reservoirs.  Impacts to coot and 
waterfowl populations are beginning to be explored. 
 Management of AVM epizootics is also an area that needs to be further 
addressed.  Considerations for management will ultimately depend upon 
determination of the source of the disease.  However, the knowledge that AVM is 
associated with aquatic vegetation, in particular invasive plants, has given 
researchers and managers an area of focus. Exotic aquatic weeds have been 
impacting the nation’s waterways since the late 1800s, and management of these 
plants is still a major area of research today (Cofrancesco, 1998). Various 
mechanical, chemical, and biological control methods have been used, with 
varying degrees of success.  Biological control, which involves the introduction 
and release of exotic insects, predators, or pathogens, is presently the predominant 
method of weed control and subject of much current research (McFayden, 1998). 
The knowledge that AVM is associated with noxious weeds adds an additional 
factor of consideration for aquatic plant managers working in AVM reservoirs. 
Researchers are currently studying sterile grass carp (Ctenopharyngodon idella)
as a potential hydrilla control agent in AVM reservoirs. Grass carp have been 
used to control aquatic weeds in the U.S. since the 1960s, with much success 
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(Masser, 2002). Current research is focused on whether or not carp are affected by 
the AVM toxin, and whether they could be a potential vector of the disease to 
predators.  Similar considerations and study should be made with other weed 
control agents currently used in reservoirs where AVM has been documented. 
The purpose of my research was to examine the putative toxin responsible 
for AVM and it consists of two major objectives.  The first objective was to 
develop an extraction procedure for isolating the toxin from its environmental 
matrix, i.e. aquatic vegetation and associated epiphytes. Without an extraction 
procedure, AVM researchers are limited to in vivo studies involving whole tissue 
or vegetative samples.  While such studies can be useful, they are limited in terms 
of the information they can provide.  Research on toxin chemistry, and eventually 
toxin isolation and identification, necessitates the isolation of the putative toxin 
from the environmental matrix.  This involved first obtaining vegetation known to 
contain the toxin (Chapter 1) then developing and testing crude extracts produced 
from this material (Chapter 2).   Once a suitable method was developed for 
extracting the AVM toxin from vegetation, further fractionation of the crude 
extract was conducted in an attempt to produce a more purified extract (Chapter 
4). 
The second major objective of this research was to develop an in vitro,
cell-based assay for detection of the AVM toxin.  An in vitro model will allow for 
rapid and sensitive detection of the toxin and can thus be used to guide toxin 
fractionation and isolation studies.  In addition, such assays can be used to study 
the biochemistry and pathology of the toxin.  Established cell lines were exposed 
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to extracts produced from both AVM-positive and AVM-negative hydrilla and 
toxicity was assessed by examining several endpoints, including cytotoxicity, 
mechanism of cell death (apoptosis v. necrosis), morphological and cytoskeletal 
changes, and cell cycle disruption (Chapter 3).  Cell cycle disruption was 
observed in one cell line and this assay was then used to track toxicity in the 
extract fractions produced in Chapter 4. 
In addition to the two main objectives, mammalian susceptibility was 
explored using a mouse model (Chapter 5).  Mice were exposed to the confirmed 
AVM-positive extracts produced in Chapter 2 by oral gavage, providing a better 
assessment of AVM susceptibility than previous mammalian toxicity studies. 
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CHAPTER 1 
INVESTIGATION OF THE LINK BETWEEN AVIAN VACUOLAR 
MYELINOPATHY AND A NOVEL SPECIES OF CYANOBACTERIA 
THROUGH LABORATORY FEEDING TRIALS 
 
Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting 
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and 
other birds in the southeastern U.S.   First observed in 1994, the cause of AVM 
remains elusive despite extensive investigation, although the pathology of the 
disease and epizootiologic studies suggest a toxin (Thomas et al., 1998; Rocke et 
al., 2002).    
 AVM is characterized by microscopic vacuolization of the white matter of 
the central nervous system, resulting from a separation of the myelin lamellae at 
the intraperiod line (Thomas et al., 1998).  This pathology is consistent with 
intramyelinic edema, a condition that can be caused by several known 
compounds, including triethyltin, hexachlorophene, and bromethalin (van Gemert 
and Killeen, 1998).  No significant concentrations of any of these compounds or 
various other environmental contaminants have been detected in tissues or 
environmental samples from AVM mortality events.  In addition, there has been 
no evidence to link AVM to infectious agents (Thomas et al., 1998; Larsen et al., 
2003).  
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 Epidemiological investigations and sentinel studies have established that 
AVM is site-specific, seasonal in occurrence, and can have a rapid onset (Rocke 
et al., 2002).  AVM generally occurs during late fall and early winter and the 
onset of disease can occur as quickly as five days after exposure to the causative 
agent.  In addition to bald eagles and American coots, several other avian species 
have been diagnosed with AVM, including mallards (Anas platyrhynchos), ring-
necked ducks (Aythya collaris), buffleheads (Bucephala albeola), Canada geese 
(Branta canadensis), great-horned owls (Bubo virginianus), and a killdeer 
(Charadrius vociferus) (Fischer et al., 2002; Augspurger et al., 2003).  Birds with 
AVM may display clinical signs, including difficulty or inability to walk, swim, 
and/or fly and general ataxia.  Not all birds with AVM lesions display these signs, 
thus microscopic evaluation of brain tissue is necessary for diagnosis.  
 Recent studies have established that AVM is acquired through ingestion 
and transferred through the food chain. Transfer of AVM from water birds to 
raptors was demonstrated when captive red-tailed hawks (Buteo jamaicensis)
developed AVM after ingesting AVM-affected coot tissue in the laboratory 
(Fischer et al., 2003).  AVM was experimentally induced in both mallards and 
domestic chickens (Gallus domesticus) through ingestion of aquatic vegetation 
(Hydrilla verticillata and associated materials) from AVM affected reservoirs 
(Birrenkott et al., 2004; Lewis-Weis et al., 2004).  
 Researchers are now examining a possible link between AVM and a 
species of cyanobacteria associated with the aquatic vegetation.  Surveys of 
epiphytic algal communities revealed the presence of a novel species of 
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cyanobacteria at all confirmed AVM sites (Wilde et al., 2005).  This species, a 
previously undescribed member of the order Stigonematales, was the dominant 
epiphyte during the AVM season in those water bodies where AVM has been 
observed most frequently and was the dominant epiphyte associated with hydrilla 
that induced AVM in laboratory mallards (Birrenkott et al., 2004). One hypothesis 
is that the etiologic agent of AVM is a neurotoxin produced by this 
cyanobacterium.  The purpose of this study was to further examine the 
relationship between the Stigonematalan species and AVM induction, using 
animal feeding trials.  In two separate trials, we attempted to induce AVM in 
animal models by feeding aquatic vegetation containing large quantities of the 
Stigonematalan species.  Control animals received vegetation of the same type 
that did not contain the Stigonematalan species.  In addition, we attempted to 
examine the time period necessary to induce AVM in the laboratory and were 
able to further explore the temporality of AVM occurrence.    
 
Materials and Methods
Study Area 
 Aquatic vegetation (Hydrilla verticillata and associated materials) was 
collected from three sites in South Carolina (SC).  Hydrilla containing the 
Stigonematalan species was collected from J. Strom Thurmond Lake (JSTL) 
(34 40’40’’ N, 82 13’0’’ W) and Davis Pond (33 42’23”N, 82 08’15”W).  JSTL is 
a 28,700 ha reservoir located on the Savannah River on the border of South 
Carolina and Georgia and is a site of previous AVM epornitics.  For this study, 
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hydrilla was collected from the Parksville Recreation Area, located along the 
southeast region of the lake.  The Stigonematalan species was the most prevalent 
epiphyte associated with the hydrilla.  Davis Pond is a 1.6 ha private pond located 
6.8 km east of JSTL. The pond had been colonized by hydrilla during the summer 
of 2003 and no AVM morbidity or mortality had been observed previously at this 
site.  At the time of the study, the Stigonematalan species was determined to be 
the most prevalent epiphytic species.  
 Control hydrilla was collected from Lake Marion, SC (33 32’18”N, 80 
16’05”W), a 44,500 ha reservoir with no known AVM morbidity or mortality.  
Hydrilla was collected from the Potato Creek Embayment area.  This site was 
chosen because it contained an abundance of hydrilla and associated epiphytes, 
but contained no observable colonies of the suspect Stigonematalan 
cyanobacteria.   American coots were also collected from this site and analyzed 
for AVM lesions to ensure that the disease was not present. 
 
Trial I 
 Mallard ducks and domestic chickens served as animal models.  Sixteen 
adult male mallards were purchased from Whistling Wings (Hanover, Illinois, 
USA) and sixteen adult female chickens were obtained from the Clemson 
University Morgan Poultry Center (Clemson, South Carolina, USA).  All birds 
were obtained 14 October 2003 and were housed in Godley-Snell Research 
Center at Clemson University.  Both species were randomly divided into two 
experimental groups, treatment and control, with eight birds in each group.  
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Animals were housed according to experimental group. Treatment birds were fed 
hydrilla from JSTL and control birds were fed hydrilla from Lake Marion.   
 Hydrilla was collected from Lake Marion 14 October 2003 and from JSTL 
7 October 2003.  Hydrilla was collected with a rake from depths of up to 1.5 m 
and transported in covered plastic containers.  A sub-sample from each site was 
examined microscopically to determine the associated epiphytes.  Three random 
entire leaves were mounted on a glass slide and the average surface area covered 
by the cyanobacterial epiphytes was measured using epifluorescence microscopy. 
Surface area coverage was classified into four categories: present (1-25%), 
common (26-50%), abundant (51-75%), or dominant (76-100%).  Real-time PCR 
was also performed to genetically confirm the presence and abundance of the 
Stigonematalan species (Williams et al., 2007), as described below.  All collected 
vegetation was frozen at -20°C.  Half of the hydrilla was distributed into gallon-
size plastic bags before freezing for use in the feeding trials and the remaining 
half was stored at -20°C for potential future toxin analysis.  Administration of 
hydrilla began 15 October 2003.  All hydrilla was thawed before feeding.  For 
mallards, hydrilla was given twice daily and placed in swim tanks for birds to 
consume ad libitum. Each group of mallards (n=8) received approximately 1000 -
1700 g wet weight (ww), although this measurement includes a substantial 
amount of water so the actual mass of hydrilla would be much less.  Chickens 
received hydrilla twice daily as well, placed in feeding trays.  Each group of 
chickens (n=8) received approximately 500-1200 g ww daily.   All birds were 
given progressively less hydrilla as the number of birds per experimental group 
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was reduced each week, as described below.   Both species received supplemental 
commercial feed for one hour twice daily and water was available ad libitum.
Behavior was observed twice daily and weights were recorded twice weekly.   
 Following the first week of feeding, one-fourth of the birds (two treatment 
and two control of both species) were sacrificed each week, with the last group of 
birds receiving hydrilla for four weeks. Birds were euthanized by CO2 and whole 
brains were removed.  Brains were placed in 10% neutral buffered formalin and 
transported to the Southeastern Cooperative Wildlife Disease Study (SCWDS, 
Athens, Georgia, USA) for analysis.   
 
Trial II 
Trial II was conducted 18 November – 17 December 2003.  Eighteen adult 
male mallard ducks were received from Whistling Wings 18 November.  Mallards 
were housed at Godley-Snell Research Center according to experimental group.   
The study sites for this trial included JSTL, Davis Pond, and Lake Marion.  
Hydrilla was collected weekly at each site during the course of the study, 
beginning 18 November.  Sub-samples of hydrilla were examined for epiphytes as 
in Trial I.  Quantitative real-time PCR was performed on select samples. 
Collection methods were identical to Trial I, with the exception that half of the 
hydrilla used in the feeding trials was kept at room temperature while the other 
half was frozen, and subsequently thawed, prior to feeding.  This was done to 
determine if freezing the hydrilla had an impact on viability of the etiologic agent.  
Therefore, birds were randomly divided into six experimental groups, with three 
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birds per group: 1) JSTL, frozen hydrilla; 2) JSTL, fresh hydrilla (kept at room 
temperature); 3) Davis Pond, frozen hydrilla; 4) Davis Pond, fresh hydrilla; 5) 
Lake Marion, frozen hydrilla; and 6) Lake Marion, fresh hydrilla.  Feeding 
methods were the same as in Trial I, with birds receiving hydrilla twice daily.   
Each group of birds (n=3) received approximately 500 to 1200 g ww daily.  
Behavior was observed twice daily and weights were recorded twice weekly.  Due 
to the smaller experimental groups (n=3) in Trial II, all birds were sacrificed after 
four weeks of feeding.  However, two birds were euthanized prior to this date 
after developing signs of neurological impairment.  Methods of euthanasia and 
brain analysis were the same as in Trial I.  
 
Real-time PCR Analysis 
 Real-time PCR analysis was conducted using methods developed by 
Williams et al. (2007).  From each environmental location tested, 0.5 g of hydrilla 
leaves were weighed.  DNA for real-time PCR was extracted using the 
UltraCleanTM Plant DNA Isolation Kit (Mo Bio Laboratories, Inc., Carlsbad, 
California, USA) following the kit protocol. All real-time PCR assays were 
conducted using the SmartCyler® System (Cepheid, Sunnyvale, California, 
USA). Reaction protocols for each assay consisted of three stages: two 
denaturation stages at 96°C for 75 s, 45 cycles at 96°C for 5 s, and an annealing 
stage at 58°C for 40 s.  Reaction mixtures from each assay consisted of two 
flanking primers and an internal fluorescent-labeled probe developed by Williams 
et al. (2007) (Stig 1069 forward primer, primer sequence  
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5'-AGGGTGGGCACTCTAAAGA-3'; Stig 1248 reverse primer, primer sequence 
5'-CAGCCTTCGATCTGAATTG-3'; Stig 1209 probe, sequence 
5'[6~FAM]CAAATCTCGTAAACCGTTGCTAATT[TAMRA~6~FAM]3'). 
The following reagents were added to each 25 Vl reaction mixture:  0.2 Vm
primers and internal probe; 1 x PCR buffer (Promega, Madison, Wisconsin, 
USA), 2.5 mM MgCl2, 0.2 mM dNTP mixture (Stratagene, La Jolla, California, 
USA), 10 VM bovine serum albumin, and 0.2 U Vl-1 Taq polymerase (Promega, 
Madison, Wisconsin, USA). 
 
Results
Trial I 
In Trial I, no birds developed any clinical signs of AVM and all brains 
were negative for AVM lesions.  Mallard body weights remained relatively 
constant over the course of the study, with an average increase of 6.1% (± 8.0% 
[SD]) and no individual weight loss exceeding 3.0%.  Mallards readily ate the 
vegetation, consuming almost all of the offered material.  The chickens consumed 
much less material than the ducks, only consuming one-third to one-half of the 
material offered and had an average weight loss of 5.4% (± 5.6%) from the 
beginning of the trial to euthanasia.  No individual weight loss exceeded 20%.     
 Cyanobacterial epiphytes associated with the vegetation collected for Trial 
I, and their relative abundance, are shown in Tables 1 and 2.   Several genera were 
present on both Lake Marion and JSTL material, with the Stigonematalan species 
dominant on JSTL vegetation and absent from Lake Marion vegetation.  Real-
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time PCR confirmed the absence of Stigonematalan colonies on Lake Marion 
material, and reported a value of 577.96 cells/ml for JSTL material. 
 
Trial II 
 In Trial II, two birds developed signs of neurological impairment 
consistent with AVM.  On the afternoon of 23 November, five days after 
initiation of the study, a member of the JSTL Fresh group was observed leaning 
backwards with a slightly unsteady gait. The bird was still eating and drinking 
readily.  On the morning of 24 November, the bird displayed more severe ataxia, 
including falling onto its side and backwards, and inability to walk properly.  At 
this time, the bird was euthanized and the brain was placed in formalin.   
 On 1 December, thirteen days after initiation of the study, another member 
of the JSTL Fresh group developed clinical signs consistent with AVM.  This bird 
was observed tilting forward and generally appeared off balance and lethargic.  
The bird was euthanized and the brain was stored in formalin.   
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Table 1. Percent leaf surface area coverage of cyanobacterial epiphytes on 
collected vegetation (Hydrilla verticillata).  Coverage was based on microscopic 
analysis of three random entire leaves and classified as either present (1-25%), 
common (26-50%), abundant (51-75%), or dominant (76-100%). 
 
Trial Ia Trial IIb
Cyanobacterial 
Genus 
 
Lake 
Marion 
 
JSTLc Lake Marion 
 
JSTL 
 
Davis Pond 
Anabaena 
Aphanothece 
Gloeotrichia 
Gomphosphaeria 
Leptolyngbya 
Microcoleus 
Oscillatoria 
Phormidium 
Pseudanabaena 
Spirulina 
Stigonematales sp. 
Trichormus 
 
Present 
Present 
Abundant 
 
Common 
 
Common 
 
Present 
Present 
 
Present 
 
Abundant 
Present 
 
Present 
Common 
Present 
Common 
Present 
 
Present 
Present 
Present 
 
Common 
 
Present 
Present 
 
Present 
Present 
 
Present 
 
Dominant 
 
Present 
 
Present 
 
Present 
 
Present 
 
Abundant 
Present 
aVegetation collected 7 October 2003 for JSTL, 14 October 2003 for Lake 
Marion. 
bVegetation collected 18 November 2003.  See Table 2 for Stigonematales 
coverage on additional collection dates. 
cJ. Strom Thurmond Lake 
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Table 2.  Percent leaf surface area coverage of the Stigonematales species on 
collected vegetation (Hydrilla verticillata).  Coverage was based on microscopic 
analysis of three random entire leaves and classified as either present (1-25%), 
common (26-50%), abundant (51-75%), dominant (76-100%), or ND (not 
detected).   Quantitative real-time PCR performed on select samples is listed in 
parentheses below coverage.   
 
Lake Marion 
 
JSTLa Davis Pond 
Trial I 
 7 October 
 
14 October 
 
Trial II 
 18 November 
 
25 November 
 
2 December 
 
9 December 
 
-----------b
ND 
 
ND 
 
ND 
 
ND 
 
ND 
 
Abundant  
(577.96 cells/ml) 
----------- 
 
Dominant 
 
Abundant 
 
Abundant  
(345.46 cells/ml) 
Abundant 
 
----------- 
 
----------- 
 
Abundant  
(162.59 cells/ml) 
Abundant 
 
Common 
 
Common 
 
aJ. Strom Thurmond Lake 
bNo collection at this site 
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All other birds in Trial II remained clinically normal during the study.  All 
weights remained relatively constant, with an average weight gain of 6.8% (± 
11.5%) over the course of the study and no individual weight loss greater than 
8.0%.  The birds readily consumed the majority of the vegetation offered.  
Microscopic examination of brain tissue revealed the presence of AVM lesions in 
ten mallards, including the two displaying clinical signs.  All six of the birds 
receiving JSTL hydrilla developed AVM, and four of the six birds receiving 
hydrilla from Davis Pond developed the disease (two out of three birds in both the 
Davis Fresh and Davis Frozen groups).  No AVM lesions were observed in any 
bird receiving hydrilla from Lake Marion.   
 Cyanobacterial epiphytes associated with vegetation collected for Trial II 
are shown in Tables 1 and 2.  The Stigonematalan species was not observed on 
Lake Marion material, though several other cyanobacterial genera were present.  
Leaf coverage of the Stigonematalan species on JSTL hydrilla was classified as 
abundant to dominant (51-100% leaf coverage), and quantitative real-time PCR 
on the 2 December 2003 collection reported a value of 345.46 cells/ml.  Leaf 
coverage for Davis Pond was classified as common to abundant (26 -75% leaf 
coverage), and quantitative real-time PCR on the 18 November 2003 collection 
reported a value of 162.59 cell/ml. 
 
Discussion
No birds in Trial I contracted AVM, apparently due to the absence or 
insufficient concentration of the causative agent in the collected vegetation.  At 
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the time there was concern about whether or not freezing the material would 
affect the viability of the AVM agent, but results from Trial II have demonstrated 
that freezing did not have an effect, which is consistent with previous studies 
(Fischer et al., 2003; Lewis-Weis et al., 2004).  Despite being housed in larger 
groups, ducks in Trial I had access to approximately the same amount of hydrilla 
as those in Trial II, and all birds appeared to eat readily.  The chickens however, 
consumed much less hydrilla than the mallards and were therefore not used in 
Trial II.   Chickens have been shown to be susceptible to AVM and an acceptable 
animal model for vegetation feeding trials in another study (Lewis-Weis et al., 
2004).       
 Ten of twelve treatment ducks in Trial II were diagnosed with AVM 
lesions, indicating that at least some vegetative samples from both JSTL and 
Davis Pond collected during November and December contained the causative 
agent in sufficient quantity to produce lesions.  The hydrilla collected from JSTL 
during the week of November 18 certainly contained the etiologic agent, as the 
bird that displayed clinical signs at five days had only consumed material from 
this collection.        
 Hydrilla was collected from the same site at JSTL for both trials; however, 
only that material collected during the second trial, collected November 18 - 
December 9, induced AVM, while material collected in October did not. The lack 
of AVM induction with earlier collections is consistent with other observations of 
AVM seasonality.  Previous studies have reported the occurrence of AVM from 
November through March or April, with the highest prevalence in November and 
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December (Rocke et al., 2002; Fischer et al., 2002).  On JSTL specifically, the 
majority of diagnostic accessions submitted to SCWDS since 1998 were found 
November – January, although active surveillance of coots on JSTL from 1998-
2004 revealed the presence of lesions from October to March (Fischer et al., 
2006).  At the time of our collections in 2003, active surveillance of coots 
revealed no prevalence of lesions in October, but lesions were present in  22% 
and 7% of coots collected in November and December, respectively (Fischer et 
al., 2006).  This marked seasonality supports the idea that AVM is the result of a 
naturally produced toxin. 
 Factors that initiate toxin production in cyanobacteria and other algal 
species are not precisely known (Haider et al., 2003).  Toxins are usually 
associated with bloom formation, which can occur in response to environmental 
factors such as a change in nutrient concentrations, temperature, or light.  In AVM 
reservoirs, the suspect Stigonematalan species experiences a bloom beginning late 
summer to early fall, occurring in abundance until the vegetation senesces during 
the winter months and it loses a suitable substrate (S. B. Wilde, unpubl. data).  
Observations of cyanobacterial epiphytes and PCR confirmed the presence of the 
Stigonematalan species during both the October and November collections.  
Comparable quantities were present for all, except for higher leaf coverage (76-
100%) for the November 18 JSTL collection than the remaining November 
collections and October collection (51-75%). 
 The fact that the October material did not produce AVM does not imply 
that the Stigonematalan species is not involved, only that it may not have been 
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actively producing toxin at the time.  While changes in algal toxin concentrations 
can often be explained by changes in algal abundance, there are many instances 
where there is no correlation between numbers of cyanobacteria and toxin 
production (Kardinaal and Visser, 2005).  The same environmental factors that 
influence bloom formation – light, temperature, pH, nutrient ratios and 
concentrations – can also influence toxin dynamics.  In addition, toxic and non-
toxic strains of cyanobacteria can occur within the same species, further 
complicating the relationship between cyanobacterial biomass and toxin presence 
and concentration (Kardinaal and Visser, 2005). 
 It was our intention in Trial I to study the time of lesion formation by 
feeding our test animals vegetation from a single collection over a one month time 
period and euthanizing them at different time points, but no birds developed 
visible AVM lesions.  However, clinical signs of AVM were observed in one bird 
five days after initial exposure to the hydrilla in Trial II.  This quick time of onset 
has been observed previously with sentinel birds released onto an AVM affected 
reservoir (Rocke et al., 2002).  It is unclear when the other birds that contracted 
AVM in the present study may have developed lesions.  
 Of the ten birds in the second feeding trial to have confirmed lesions 
consistent with AVM, two were observed with clinical signs of the disease.  This 
frequency is consistent with the previous laboratory trial that successfully 
reproduced AVM in mallards, in which one of six ducks with confirmed lesions 
displayed clinical signs (Birrenkott et al., 2004).  It is not clear why some birds 
display clinical signs and others do not.  It may be related to the amount of the 
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etiologic agent that the bird ingests, the duration of exposure, variation in 
individual susceptibility and health of the bird, or some other factor.  Lewis-Weis 
et al. (2004) reported a higher prevalence of clinical signs in chickens affected 
with rickets than in birds of good nutritional status.  The mallards developing 
clinical signs in this study did not have any obvious signs of impaired health 
compared to the other birds, but could have had undetected conditions making 
them more susceptible.  Thus far there appears to be no correlation between 
presence of clinical signs and severity of brain lesions.  Birds with severe lesions 
can appear clinically normal while those with signs of neurological impairment 
can have mild to moderate lesions (Rocke et al., 2002; Fischer et al., 2003).   
Regardless of the reason, it is clear that many birds that develop AVM lesions do 
not develop clinical signs.  This suggests that the disease may go undiagnosed 
unless active surveillance is conducted. 
 While not conclusive, this study provides further evidence that AVM 
induction may be linked to a newly discovered cyanobacterial species.  At the 
least, this novel Stigonematalan species appears to be a good indicator of AVM 
disease potential, as material collected from two separate study sites based on the 
presence of this species induced AVM.  We were able to correctly predict the 
presence of the AVM causative agent in Davis Pond due to the existence of two 
factors: the abundant submerged aquatic vegetation and the associated abundant 
Stigonematalan cyanobacteria.   However, since the control and treatment hydrilla 
were collected from different study sites, factors other than presence or absence of 
the Stigonematalan species may be involved and further study is needed.  
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Vegetation collected from the same reservoir, some containing the 
Stigonematalan species and some without, would provide more convincing 
evidence.  However, no reservoirs provided such a situation at the time of our 
collections.  In addition, due to the nature of the epiphytic growth of 
cyanobacteria on the vegetative material, it is impractical, and perhaps not 
possible, to separate the cyanobacterial colonies from the vegetation in order to 
test it separately.  
 The Stigonematalan species is currently being cultured in the laboratory 
and future experiments include the testing of this material by mallard bioassay.  In 
addition, experiments are underway involving attempts to extract the putative 
AVM toxin from collected vegetation samples.   Much research is still needed to 
determine the cause of AVM, as well as to provide more information on the 
pathology, range of susceptible species, implications for wildlife populations, and 
management strategies. 
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CHAPTER 2 
AN EXTRACT OF HYDRILLA VERTICILLATA AND ASSOCIATED 
EPIPHYTES INDUCES AVIAN VACUOLAR MYELINOPATHY IN 
LABORATORY MALLARDS 
 
Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting 
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and 
other birds in the southeastern U.S.   First observed in 1994, AVM is responsible 
for the deaths of over 100 bald eagles and estimates of over a thousand coots 
(Wilde et al., 2005).   
 AVM is characterized and diagnosed by a spongy degeneration of the 
white matter of the central nervous system, specifically an intramyelinic edema 
(Thomas et al., 1998).  Affected birds may display clinical signs of neurological 
impairment, including difficulty in flying, swimming, and/or walking.  However, 
not all birds with AVM lesions display clinical signs, thus pathological evaluation 
of brain tissue is necessary for diagnosis.  The pathology of AVM is consistent 
with several known chemicals, including triethyltin, hexachlorophene, and 
bromethalin (van Gemert and Killeen, 1998), but no significant concentrations of 
these or other known toxins have been detected in tissues of affected birds or 
environmental samples (Thomas et al., 1998; Dodder et al., 2003).  There has also 
been no evidence linking AVM to infectious agents and the disease was not found 
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to be contagious (Thomas et al., 1998; Larsen et al., 2003).  Although the etiology 
of the disease remains unknown, recent investigations have suggested that the 
causative agent for AVM is a cyanobacterial toxin (Birrenkott et al., 2004; Wilde 
et al., 2005; Wiley, 2007, Chapter 1).   
 Previous investigations have established that AVM is site-specific and 
seasonal (Rocke et al., 2002), associated with a number of southeastern reservoirs 
with epizootics occurring during late fall to early winter.  Coots and other 
waterfowl contract the disease by feeding on aquatic vegetation (Birrenkott et al., 
2004; Lewis-Weis et al., 2004; Rocke et al., 2005), and bald eagles and other 
avian predators contract the disease by consuming affected prey (Fischer et al., 
2003).   All AVM-affected reservoirs contain extensive exotic aquatic 
macrophytes, but the same or similar macrophytes are also abundantly present in 
other nearby aquatic systems where AVM is not observed.  Therefore, it has been 
hypothesized that the causative agent is something associated with the 
macrophytes, rather than the macrophytes themselves (Birrenkott et al., 2004; 
Lewis-Weis et al., 2004).  
 The macrophyte hydrilla (Hydrilla verticillata), that induced AVM in a 
laboratory controlled, mallard (Anas platyrhynchos) feeding study (Birrenkott et 
al., 2004), was shown to contain large quantities of an epiphytic cyanobacterial 
species.  Colonies of this species, a previously uncharacterized member of the 
order Stigonematales (Williams et al., 2007), covered 50-90% of the leaf surface 
of the hydrilla.  Surveys of all known AVM reservoirs, and similar reservoirs 
where AVM does not occur, revealed a strong positive correlation between the 
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presence of this cyanobacterial species and AVM (Wilde et al., 2005).  
Researchers have thus postulated that this cyanobacterial species may be 
producing a toxin that causes AVM in birds such as eagles and coots. 
 Cyanobacteria are ubiquitous in fresh, marine, and brackish waters, as 
well as terrestrial environments all over the globe.  Numerous genera are known 
to produce toxins, which can have hepatotoxic, neurotoxic, or dermatotoxic 
effects in human and wildlife populations (Codd, 1995).  The current list of 
known toxins is incomplete, as new and emerging toxins are recognized due to 
advances in analytical techniques and an increasing awareness of the potential for 
cyanotoxin poisoning events (Codd, 1995; Codd et al., 2001; Cox et al., 2005). 
To date investigations on AVM have been limited to feeding studies 
utilizing whole tissues or vegetation samples without any quantitative indication 
of the presence of the AVM toxin.  The aim of the present study was therefore to 
develop a method to extract the causative agent of AVM from aquatic vegetation 
as the first step towards purification and characterization of the AVM toxin.  
Successful isolation of a partially purified toxic extract will provide an invaluable 
tool for in vitro and in vivo toxicology studies including investigations 
determining the mechanism of action.   
 
Materials and Methods
Vegetation Collection 
 
Hydrilla was collected from J Strom Thurmond Lake (JSTL), South 
Carolina, USA, a site of previous and current AVM epizootics (Fischer et al., 
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2002; Fischer et al., 2003; Lewis-Weis et al., 2004).  This vegetation contained 
abundant quantities of an epiphytic cyanobacterium that has been suggested as a 
possible source of the disease agent (Wilde et al., 2005), with leaf surface area 
coverage ranging from 51-100%.  Control hydrilla was collected from Lake 
Marion, South Carolina, USA, a reservoir with no known history of AVM 
occurrence.  The suspect cyanobacterium was absent in all collections made from 
Lake Marion, as confirmed by microscopic analysis of representative leaves. 
Samples were collected weekly, for four weeks, from mid-November to 
mid-December 2003. Collections were made with a rake, from the surface to a 
depth of approximately 1.5 m, and samples were stored and transported in 
covered plastic containers (200 L, Rubbermaid, Atlanta, Georgia, USA).  Excess 
water was drained and samples were stored at -20°C, except as described below 
for the mallard vegetation bioassay. 
 
Mallard Bioassay I - Vegetation 
To confirm the presence or absence of the AVM causative agent, half of 
the vegetation collected was fed ad libitum to farm-reared mallard ducks in the 
laboratory.  Detailed results of this study are reported in Chapter 1 (Wiley, 2007).  
Briefly, six ducks were fed vegetation from JSTL and six ducks fed vegetation 
from Lake Marion.  Three ducks in each group received fresh vegetation that had 
not been frozen, but kept at room temperature.  The remaining three ducks 
received vegetation that had been frozen at -20°C, and thawed prior to feeding.  
All six ducks receiving JSTL vegetation developed white matter lesions consistent 
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with AVM, confirming the presence of the AVM agent.  No ducks receiving Lake 
Marion vegetation developed AVM lesions, confirming the absence of the AVM 
agent.  This trial also confirmed that freezing does not affect stability of the AVM 
causative agent. 
 
Toxin Extraction  
The remaining half of the collected vegetation was used for a solvent 
extraction procedure.  Frozen vegetation was lyophilized (Virtis Company, 
Gardener, New York, USA) and blended (Waring Commercial Blender, Waring, 
Torrington, Connecticut, USA) at medium speed for 1 min into a coarse powder 
in preparation for extraction.   Each of the four weekly samples of vegetation was 
lyophilized and extracted separately, and dry weight of each sample was recorded 
prior to extraction.  Dry weights of weekly samples ranged from 418.48 – 1219.88 
g, with an average of 837.83 g.  Dried, powdered vegetation was loaded evenly 
into three to four, 2 L separatory funnels (200-300 g per funnel) and sequentially 
extracted with hexanes, acetone and methanol (Fisher Chemical, HPLC grade, 
Fisher Scientific, Hampton, New Hampshire, USA).  Solvent was added to the 
vegetation until saturated (1-1.5 L of solvent per funnel) and the sample was 
mechanically extracted by shaking for five, 2 min periods over 1 h.  The extract 
was then allowed to drain, and the sample was rinsed with a final volume of 
solvent (0.5 L).  Drained solvents were pooled.  This process was then repeated 
with the next solvent.  The collected extracts were filtered through 70 mm 
Whatman qualitative grade filter paper (Whatman, Inc., Florham Park, New 
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Jersey, USA) to remove particulates, and solvent was removed by a rotary 
evaporator (Buchi Rotavapor, Buchi, Flawil, Switzerland) with a water bath set no 
higher than 28°C.  When dry, the extracts were re-suspended in the appropriate 
volume of solvent to a concentration of 10 g vegetation/ml solvent, based on the 
initial dry weight of the vegetation.  Ten percent of this volume was archived for 
future in vitro experiments, and the remaining 90% was transferred to a glass 
storage jar for use in the in vivo mallard extract bioassay.  All extracts were stored 
at -20°C.   
 
Mallard Bioassay II - Extracts 
 In order to determine whether any extract(s) contained the AVM causative 
agent, they were evaluated by a mallard bioassay.  Eighteen adult male mallards 
(average body weight: 1017 g) were obtained from Frost Waterfowl Trust 
(Georgetown, South Carolina, USA) and housed in separate floor pens by 
experimental group at Godley-Snell Research Center, Clemson University.   Birds 
were weighed upon arrival and randomly assigned to one of six experimental 
groups (three birds per group): JSTL hexanes extract, JSTL acetone extract, JSTL 
methanol extract, Lake Marion hexanes extract, Lake Marion acetone extract, and 
Lake Marion methanol extract.  Commercial feed and water were provided ad
libitum, except as described for gavage.   Birds were allowed to acclimate for 
three days prior to initiation of treatment.   
Prior to dosing, extracts were dried under a N2 stream and re-suspended in 
non-toxic vehicles.  Hexanes extracts were re-suspended in corn oil (MP 
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Biomedicals, Irvine, California, USA), acetone extracts were re-suspended in a 
50:40:10 (v:v:v) mixture of corn oil: deionized water: propylene glycol (EMD 
Chemicals, Gibbstown, New Jersey, USA), and methanol extracts were re-
suspended in a 90:10 (v:v) mixture of deionized water: propylene glycol.  Each 
weekly vegetative extract was re-suspended and dosed separately over the course 
of 1 week (4 weeks in total), so as to mimic the conditions in the mallard 
vegetation bioassay.  This was done to avoid a possible dilution of the toxin if 
weekly collections had contained differing toxin concentrations.  Extracts were 
re-suspended in the appropriate volume of vehicle to deliver the entire extract in 
three equivalent doses over one week.  Week one extracts were re-suspended in 
45 ml of vehicle, to provide a 5 ml dose volume per duck/per dosing.  Dose 
volume was reduced to 4 ml following the first week in an attempt to reduce 
regurgitation that occurred with some birds, as explained in the results section.  
Therefore, the remaining extracts were re-suspended in 36 ml, to provide a 4 ml 
dose volume per bird/per dosing.  
Mallards were orally gavaged with the re-suspended extracts three times a 
week for four weeks.  Administration of the extracts was immediately followed 
by a rinse of the respective vehicle to help wash residual extract out of the feeding 
tube.  Initial rinse volumes were 3 ml, but were reduced to 2 ml following the first 
week of dosing due to the observed regurgitation. Therefore, total dose volume 
including extract and rinse was 8 ml during the first week and 6 ml for the 
remainder of the study.  Food was removed approximately 4 h prior to treatment 
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and provided immediately post-treatment.  Birds were observed for at least 30 
min post-treatment and any regurgitation was noted.   
All birds were observed twice daily during the duration of the study and 
weights were recorded twice weekly.  Birds were euthanized three days following 
the final dose administration, 28 d after the treatment was initiated.  Birds were 
sacrificed by CO2 asphyxiation with a Euthanex CO2/O2 blending system 
(Euthanex E-23000, Euthanex Corporation, Palmer, Pennsylvania, USA), using a 
70:30 CO2:O2 mixture until birds lost consciousness, followed by 100% CO2 to 
complete euthanasia.  Whole brains were removed and placed in 10% neutral 
buffered formalin in preparation for AVM diagnosis.  Whole blood and other 
tissues, including liver, kidney, pectoral muscle, gizzard, intestines, and adipose 
tissue were also collected and archived at -20°C.  Brain analysis was conducted at 
the Southeastern Cooperative Wildlife Disease Study by methods previously 
described (Fischer et al., 2003).  
 
Results
No clinical signs of neurological disease, including ataxia, incoordination, 
or lethargy, were observed during the trial.  All animals maintained a fairly 
constant body weight throughout the study.  On day 15 of the treatment period, a 
bird in the AVM-positive methanol group broke a wing during removal from the 
pen for treatment.  This bird was immediately euthanized and necropsied.   
Following gavage, several birds were observed regurgitating the 
administered dose, usually within five minutes of administration.  This occurred 
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in the JSTL and Lake Marion methanol groups following the first two treatments, 
with at least one bird in both groups regurgitating.  Since the birds were housed in 
groups, we were unable to determine with confidence how many birds 
regurgitated or which bird regurgitated unless it was observed directly.  In an 
attempt to prevent regurgitation, the total dose volume was reduced to 6 mL, as 
previously described.   Following the next two dose administrations, at least one 
bird in both methanol groups again regurgitated.  However, for all successive 
treatments, no regurgitation was observed in the Lake Marion methanol group.  At 
least one bird, and often all birds, in the JSTL methanol group continued to 
regurgitate after each treatment.  In addition, at least one bird in the JSTL acetone 
group regurgitated three times during the study, and at least one bird in the JSTL 
hexane and Lake Marion acetone groups regurgitated once.    The occurrences of 
regurgitation by experimental group are shown in Table 3.  There was a 
significant difference in the occurrence of regurgitation between the JSTL 
methanol group and all other groups (p<0.001, Fisher’s exact test).   
The results of the brain analysis are shown in Table 4.  All three birds in 
the JSTL methanol group developed definitive lesions of moderate severity 
consistent with AVM (Figure 1).  One bird in the JSTL acetone group developed 
possible mild lesions (Figure 2).  All other birds had no apparent lesions (Figure 
1).  Brain slides are archived at the Marine Resources Research Institute, South 
Carolina Department of Natural Resources, Charleston, South Carolina, USA. 
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Table 3.  Occurrence of regurgitation in mallards after administration of an extract 
of Hydrilla verticillata and associated epiphytes collected from Lake Marion, 
South Carolina or J. Strom Thurmond Lake, South Carolina. 
 
Lake Marion J. Strom Thurmond Lake 
Extract 
Doses 
n
Doses Regurgitateda
n
Doses 
n
Doses Regurgitateda
n
Hexanes 
Acetone 
Methanol 
 
12 
12 
12 
 
0
1
4
12 
12 
12 
 
1
3
12 
aIndicates the number of times at least one bird in group regurgitated. 
 
Table 4. Presence of AVM-type brain lesions in mallards after administration of 
an extract of Hydrilla verticillata and associated epiphytes collected from Lake 
Marion, South Carolina or J. Strom Thurmond Lake, South Carolina. 
 
Lake Marion 
 
J. Strom Thurmond Lake 
Extract 
n Birds with 
lesions 
n Birds with 
lesions 
Hexanes 
Acetone 
Methanol 
 
3
3
3
0
0
0
3
3
3
0
1a
3
aPossible mild lesions.  Results inconclusive. 
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Figure 1.  Light micrograph images of brain sections of mallards given J. Strom 
Thurmond Lake methanol extract (A, B, C) or Lake Marion methanol extract (D).  
A, B, and C have definitive lesions of moderate severity in the white matter tracts 
(arrows) and were diagnosed as having AVM. Brain D has no observable lesions 
and was diagnosed as not having AVM. 
A250 m
250 m B
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Figure 1.  Light micrograph images of brain sections of mallards given J. Strom 
Thurmond Lake methanol extract (A, B, C) or Lake Marion methanol extract (D).  
A, B, and C have definitive lesions of moderate severity in the white matter tracts 
(arrows) and were diagnosed as having AVM. Brain D has no observable lesions 
and was diagnosed as not having AVM (Continued). 
D250 m
C250 m
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Figure 2.  Light micrograph image of the optic lobe of a mallard gavaged with J. 
Strom Thurmond Lake acetone extract.  Mild lesions are visible in the outer layer 
of white matter (arrow) but were not definitive.  Therefore a diagnosis of AVM 
was not made. 
 
Discussion
This study describes the successful extraction of the putative AVM toxin 
from hydrilla and its associated epiphytic cyanobacterial flora.  Results of 
previous studies have ruled out many other hypothesized toxicants, including 
bacterial and viral agents, and the disease was not found to be contagious 
(Thomas et al., 1998; Larsen et al., 2003).  The pathology of AVM was consistent 
with acute toxicosis, with lesions similar to those caused by known toxicants and 
no observed immune response (Thomas et al., 1998).   
250 m
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The toxin appears to be efficiently extracted with methanol, suggesting a 
polar compound.  One bird administered the acetone extract had possible mild 
lesions, though the results were inconclusive. If this bird did indeed have AVM, it 
would not be surprising that toxin was also present in the acetone extract, as the 
polarity of acetone and methanol do not differ greatly (Snyder, 1978; Marcus, 
1998; Fitzpatrick and Dean, 2002).  Both solvents also have similar octanol/water 
partition coefficients (Kow acetone = -0.24; methanol = -0.70) (Marcus, 1998).  
Methanol, however, has a much greater hydrogen bonding ability than acetone 
(Marcus, 1998; Fitzpatrick and Dean, 2002), another factor which can play a role 
in extraction efficiency.  It is also important to remember the matrix effects that 
could be involved in the extraction process. While hexanes or acetone could have 
similar properties to the toxin, methanol may have been required to release the 
toxin from interactions within the matrix.  Therefore, while it appears the toxin is 
polar, further fractionation of the crude extract will be necessary to provide a 
more accurate and detailed description of its physical properties. 
The AVM toxin appears to be stable, surviving at -20°C for at least one 
year and at room temperature for at least several days.  The highest temperature to 
which the extracts were exposed was 28°C.  It is not known whether or not the 
toxin would be stable at higher temperatures.  In addition, the toxin does not 
appear to be volatile, as it survived extensive lyophilization and vacuum 
concentration.  However, since the toxin is not known there is no method 
available to quantify its concentration and we cannot gauge the efficiency of the 
extraction procedure or rates of degradation or loss.  
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No typical clinical signs of disease were observed in the AVM-positive 
mallards; however, previous field and laboratory data have shown that many 
pathologically affected birds do not display signs of disease (Rocke et al., 2002; 
Fischer et al., 2003; Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et al., 
2005).  It is not yet known why some birds develop clinical signs whereas others 
do not.  The occurrence and severity of clinical signs has not been positively 
correlated to the severity of brain lesions.  Toxin concentration, exposure time, 
route of administration, and individual susceptibility or health status of the bird 
may play a role.  Birds with severe lesions can appear clinically normal while 
birds displaying signs of neurological impairment may have mild or moderate 
lesions (Rocke et al., 2002; Fischer et al., 2003).  It is possible that the lesions are 
unrelated to clinical signs, and that a second, unidentified pathology exists. 
 The results of this study suggest that the extracted AVM toxin elicits an 
emetic response.  Birds in the AVM methanol group that developed lesions 
consistently regurgitated following dose administration.  While birds in several 
other dose groups, including controls, also regurgitated during the study, they did 
not do so consistently.  Regurgitation as a method of rejection has not been noted 
previously in other AVM research; however, this is the first study to administer 
the putative toxin in a concentrated form.  Previous studies that have been 
successful at reproducing AVM in the laboratory have used either AVM 
contaminated vegetation (i.e., Hydrilla verticillata) or AVM positive coot tissues 
administered ad libitum (Fischer et al., 2003; Birrenkott et al., 2004; Lewis-Weis 
et al., 2004; Rocke et al., 2005).  Nonetheless, mallards are prone to a 
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regurgitation response during toxicity testing which may be caused by the test 
substance itself, the volume administered, the vehicle or dosing technique, or a 
combination of these factors (OECD, 2002).  The mid-experiment reduction in 
dosing volume may have helped prevent regurgitation in the Lake Marion 
methanol group, but it had no effect on the frequency of regurgitation for the 
JSTL methanol birds.  Many known toxins and toxicants are known to have an 
emetic effect, and it is possible that the AVM toxin is responsible for the 
increased frequency of regurgitation observed in the affected birds. 
 The time of disease onset for the affected birds is not known.  At least one 
bird developed lesions within two weeks of treatment initiation, as the mallard 
euthanized due to a broken wing at day 15 of the treatment period was diagnosed 
with AVM.  Previous studies have shown that clinical signs and lesions can 
develop as early as five days post-exposure to the causative agent (Rocke et al., 
2002; Wiley, 2007, Chapter 1).  It is not known whether or not disease onset 
occurs with a single acute exposure of a threshold concentration or can develop 
after chronic exposure to lower concentrations. 
The results of the current study provide further evidence that the 
etiological agent of AVM is associated with aquatic vegetation such as hydrilla 
and is most likely not the vegetation itself, but rather something associated with 
the vegetation, given that the birds receiving Lake Marion control hydrilla 
extracts did not develop AVM lesions.  Our working hypothesis is that AVM is 
caused by an algal or cyanobacterial toxin.  The seasonal nature of AVM 
epornitics supports this hypothesis, as algal and cyanobacterial blooms are 
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successional with seasonal changes.  Wilde et al. (2005) conducted algal surveys 
at all known sites of AVM epornitics, as well as additional control reservoirs, to 
look for algal or cyanobacterial species that were unique to AVM sites or of 
unusual abundance during the AVM season.  A previously uncharacterized 
cyanobacterium of the order Stigonematales emerged as the prime suspect.  This 
epiphytic cyanobacterium was associated with lake vegetation, particularly 
hydrilla, was observed consistently at all known AVM sites, and was the 
dominant epiphyte present at most AVM sites during the late fall to early winter, 
when AVM is commonly observed (Wilde et al., 2005).   At sites where AVM 
birds are diagnosed most consistently, the Stigonematalan species covered up to 
95% of the leaf surface area of the vegetation during these months.  In addition, at 
control sites where AVM diagnosed birds are noticeably absent, the 
Stigonematales cyanobacterium was not dominant (<10% of the leaf surface area) 
and only infrequently observed. 
 The vegetation used in the present study was selected based on the recent 
AVM histories of each study site in addition to the presence or absence of the 
Stigonematalan species.  JSTL hydrilla producing AVM was extensively covered 
by the Stigonematalan species, with 50-100% of the leaf surface area covered 
with colonies.  In contrast, Lake Marion hydrilla, while containing numerous algal 
and cyanobacterial epiphytes, contained no Stigonematalan colonies, based on 
microscopic evaluation as well as genetic analysis using real-time PCR (Wiley, 
2007, Chapter 1).  While the most obvious differences in the JSTL and Lake 
Marion vegetation is the presence or absence of the Stigonematalan species, there 
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could be other unknown factors involved in disease onset.  To confirm the link 
between the Stigonematalan cyanobacteria and AVM, the disease must be 
demonstrated from direct exposure of birds to pure cultures of the cyanobacteria 
species.   
Many questions remain to be answered regarding AVM.  In addition to 
determining the source of disease, research is needed concerning the pathology, 
range of susceptible species, and potential management strategies.  Mechanism of 
action, exposure times and concentrations necessary to produce the disease, acute 
versus chronic exposure effects, and possible recovery and/or antidote strategies 
are all unknown.  Although species susceptibility is currently confined to birds, 
the list of susceptible species continues to grow, where in particular, research 
focused on mammalian susceptibility is greatly needed.  To date, no mammals 
have been positively diagnosed with AVM in the wild; however, there has been 
anecdotal evidence of possible clinical signs in a beaver (Castor canadensis)
(Lewis-Weis et al., 2004).  Several subsequent laboratory studies have 
investigated mammalian susceptibility in mice and swine, yet none of these 
animals developed lesions (Lewis-Weis et al., 2004; Rocke et al., 2005).  The 
authors note, however, that the quantities consumed or duration of exposure may 
not have been adequate to induce disease. 
 The successful extraction of the toxin responsible for AVM will assist in 
answering many of the questions remaining about AVM, its etiologic agent, and 
its mode of action.  In addition to being the first step toward isolating and 
characterizing the toxin, this successful extraction protocol for separation of the 
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AVM toxin from an environmental matrix (i.e., hydrilla – cyanobacterial 
complex) will result in numerous opportunities for further research.   Researchers 
are currently limited to nonspecific, whole animal studies, for which large 
quantities of vegetation or tissue samples are required.  The production of a toxic 
extract through an efficient solvent extraction protocol will improve the utility of 
in vivo studies and allow for testing of additional animal models such as mice that 
may not readily consume vegetation.  In addition, the ability to extract the 
putative toxin will allow for in vitro testing.  In vitro studies using cell and tissue 
cultures would provide essential data on the pathology and mechanism of action.  
Identification of an appropriate in vitro model will also provide a more rapid and 
sensitive toxin detection method than whole animal bioassays, which will be an 
essential tool for bioassay-guided fractionation for toxin purification and chemical 
characterization. 
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CHAPTER 3 
IN VITRO TOXICITY ASSOCIATED WITH THE ETIOLOGIC AGENT OF 
AVIAN VACUOLAR MYELINOPATHY 
 
Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting 
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana), and 
other avian species in the southeastern U.S.  Since the first recorded AVM 
epizootic in 1994, over 100 bald eagles have died from the disease, and thousands 
of coots have been affected.  The cause of AVM has yet to be determined, 
although it is associated with consumption of aquatic vegetation – or animals that 
have consumed aquatic vegetation – (Birrenkott et al., 2004; Lewis-Weis et al., 
2004; Rocke et al., 2005) and has been linked to a novel cyanobacterial species in 
the order Stigonematales that grows on the vegetation (Wilde et al., 2005).  The 
etiologic agent of AVM is thought to be a toxin, and it has been hypothesized that 
the epiphytic cyanobacterium is the source of that toxin. 
 AVM is characterized by a separation of the layers of the myelin sheaths 
in the central nervous system, a condition known as intramyelinic edema (Thomas 
et al., 1998).  The brain tissue of AVM affected birds has a spongy appearance 
under light microscopy due to the vacuoles formed from the separated layers.  
Several compounds are known to cause this type of lesion, including triethyltin, 
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hexachlorophene, bromethalin, and others, but none of these compounds have 
been implicated in AVM. 
 The only current means of detecting and studying the AVM toxin is by in 
vivo animal studies.  These studies have utilized several avian and mammalian 
species as animal models, typically last one to six weeks, and involve the 
administration of large quantities of vegetation, tissues, or other test materials.  It 
is through these studies that researchers have been able to locate the source of 
exposure to the AVM toxin (aquatic vegetation and associated epiphytes), have 
demonstrated the conveyance of toxicity from prey items to predators (Fischer et 
al., 2003), and have explored mammalian susceptibility (Lewis-Weis et al., 2004). 
 Despite the utility of in vivo studies they have numerous disadvantages.  
The trials are labor intensive, generally require large quantities of test material, 
and take extensive time to plan and conduct.  The endpoint of these studies – the 
determination of AVM characteristic lesions in the brain – also takes time to 
analyze.   The purpose of this study was therefore to develop an in vitro, cell 
based bioassay for AVM toxin detection that could be used as an alternative to the 
large scale in vivo assays.  In addition to reducing the need for animal subjects, an 
in vitro assay would allow for small-scale testing, using minimal amounts of the 
test solution/substance.  The high throughput design and rapid analysis time of 
many of these assays allows for testing large numbers of experimental groups and 
replicates quickly and can therefore be used as an efficient guide to track toxicity 
in toxin fractionation experiments.  In vitro assays also represent a simplified 
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system in which cellular mechanisms and damage may be more easily explored 
and detected to study toxin mechanisms of action. 
 We have been successful at extracting the causative agent of AVM from 
vegetative samples (Wiley, 2007, Chapter 2).  Crude extracts were produced from 
vegetation collected at both AVM-positive and AVM-negative sites and examined 
for toxicity by a mallard (Anas platyrhynchos) bioassay, which subsequently 
identified the crude methanol extract as containing the active toxin.  The ability to 
produce these extracts has now allowed for the possibility of studying the AVM 
toxin in vitro. The purpose of this study was to examine the in vitro toxicity of 
these crude methanol extracts in an attempt to discover an endpoint that could be 
used in identifying AVM toxin presence in a sample.  Since the extracts were in a 
crude form, containing a large mixture of potentially bioactive compounds 
associated with the vegetation and the associated epiphytic communities, 
vegetative extracts from AVM-negative sites served as controls in all 
experiments.    
 Established cell lines served as the experimental model in all assays.  
Established, or immortal, cell lines are those that can replicate indefinitely in 
culture, being either derived from tumors or transformed to allow for indefinite 
division.  They have several advantages over primary cultures, which are derived 
from animal tissues directly prior to testing and have a finite number of divisions.  
Established cultures are easily obtained from cell culture collections and easily 
maintained in the laboratory.  These cell lines have yielded documented results 
and their strengths and weaknesses are well known.  They allow for high 
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reproducibility between experiments and laboratories and are therefore a good 
system to use for in vitro assay development.   
 
Materials and Methods
Cell Culture 
To investigate the in vitro toxicity of the crude extracts, initial experiments 
examined the cytotoxic potential of the extracts to four established cell lines.  
Three mammalian cells lines were tested: two neuronal lines, PC-12 and Neuro-2a 
(N2a), and one glial line, C6.  These cells are utilized routinely in the research 
community and a large body of literature exists on all.  A quail neuroretinal cell 
line (QNR/D) was also included in the experiments as it was the only avian 
neuronal line available as an established culture.  In addition to the cytotoxicity 
tests, extracts were further tested on C6 cells for the ability to induce apoptosis, 
cytoskeletal changes, and cell cycle disruption.   
 C6, PC-12, Neuro-2a (N2a) and QNR/D cells were obtained from the 
American Type Culture Collection (ATCC).  C6 and PC-12 cells were maintained 
at 37°C with 5% CO2 in Kaighn’s modification of Ham’s F12 medium with 2mM 
L-glutamine modified to contain 1.5 g/L sodium bicarbonate and supplemented 
with 15% horse serum and 2.5% fetal bovine serum.  N2a cells were maintained 
at 37°C with 5% CO2 in RPMI medium supplemented with 10% fetal bovine 
serum and 1.0 mM sodium pyruvate.  QNR/D cells were maintained at 39°C with 
5% CO2 in Dulbecco’s Modified Eagle’s medium modified to contain 4.5 g/L 
glucose and 1.5 g/L sodium bicarbonate, supplemented with 10% fetal bovine 
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serum.  C6 and N2a cells were routinely passaged twice weekly and QNR/D and 
PC-12 cells were passaged weekly.  Cells in passages 5-30 were used in assays.  
All cells were grown in the absence of antibiotics. 
 
Vegetation Extractions  
 All extracts were produced using methods developed in Chapter 2 (Wiley, 
2007).  Locations and dates of vegetation collections are shown in Table 5.  
AVM-positive extracts are defined as those collected at sites with a known history 
of AVM.  The Stigonematalan cyanobacterium that has been linked to AVM was 
also present in these samples, as confirmed by microscopic examination 
(Williams, unpubl. data).  AVM-negative extracts are defined as those collected 
from sites with no known history of AVM.  Samples collected at these sites did 
not contain the Stigonematalan cyanobacteria, as confirmed by microscopic 
examination and PCR (Williams, unpubl. data).  Frozen vegetation was 
lyophilized (Virtis Company, Gardener, New York, USA) and blended (Waring 
Commercial Blender, Waring, Torrington, Connecticut, USA) into a coarse 
powder in preparation for extraction and dry weight was recorded.  Dried, 
powdered vegetation was then sequentially extracted with hexanes, acetone and 
methanol (Fisher Chemical, HPLC grade, Fisher Scientific, Hampton, New 
Hampshire, USA), filtered, and reduced by vacuum concentration. When dry, the 
extracts were re-suspended in the appropriate volume of solvent to a 
concentration of 10 g vegetation/ml solvent, based on the initial dry weight of the 
vegetation.  Prior to cell testing, extracts were sterile filtered through 0.2 Vm
Table 5. Date of collection and location for vegetation extracted for use in the in vitro experiments. “AVM-negative” refers to those
sites which have no previous history of AVM. “AVM-positive” sites are those that have had documented AVM epizootics.
Sample ID Collection Site Collection Date
AVM-negative
Potato Creek-Aa
Potato Creek-B a
Dens Swamp
SCWMA
Lake Istokpoga
AVM-positive
Parksville-A ab
Parksville-B ab
Petersburg ab
Woodlakeb
DeGray
Potato Creek Embayment, Lake Marion, South Carolina
Potato Creek Embayment, Lake Marion, South Carolina
Dens Swamp Cove, Lake Marion, South Carolina
Santee Cooper Wildlife Management Area, South Carolina
Lake Istokpoga, Florida
Parksville Cove, J. Strom Thurmond Lake, South Carolina
Parksville Cove, J. Strom Thurmond Lake, South Carolina
Petersburg Cove, J. Strom Thurmond Lake, Georgia
Woodlake, North Carolina
DeGray Lake, Arkansas
14 October 2003
17 November 2003
21 December 2005
6 December 2006
12 December 2006
18 November 2003
25 November 2003
1 December 2005
22 November 2005
27 November 2006
aSamples validated by mallard bioassay.
bSamples were collected during documented AVM epizootics.
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syringe filters (Waters Corporation, Milford, Massachusetts, USA).  All extracts 
were stored at -20°C and crude methanol extracts were used in the assays.  
 
Cytotoxicity Assays 
MTT. Cytotoxicity was determined by measuring 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyl tetrazolium bromide (MTT) reduction, a measure of metabolic 
activity.  Live cells (or metabolically active cells) are able to reduce MTT, 
normally a yellow color, into purple formazan crystals, which are solubilized and 
measured spectrophotometrically to indicate the number of viable cells present in 
relation to a control population.  C6 cells were plated at 1 x 105/ml, N2a and PC-
12 at 2 x 105/ml, and QNR/D at 3.5 x 105/ml in 96-well plates at 100 Vl per well 
and allowed to attach overnight. Cells were dosed with crude methanol extract 
from Parksville-A (AVM-positive) and Potato Creek-B (AVM-negative), at 
3.125, 6.25, 12.5, 25, 50, and 100 mg/ml.  Control (no addition) and vehicle 
control (methanol only) groups were also included.  All doses were added in 1 Vl
volumes (1% of total volume in well).  Following exposure for 24 h, media was 
removed and replaced with new media containing 0.8 mg/ml MTT.  Cells were 
further incubated 2 h at 37°C (C6, N2a, PC-12) or 3 h at 39°C (QNR/D).  
Following incubation, media was removed and 100 Vl DMSO added to solubilize 
the MTT crystals.  Absorbance was measured on a NOVOStar microplate reader 
(BMG Lab Technologies, Offenburg, Germany) at 544 nm.  Background 
absorbance (from media only) was subtracted from all values.  Triplicate wells 
from each treatment were averaged and expressed as percent of vehicle control.   
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Each extract was tested in 3-4 different culture preparations and average means 
from the independent tests were compared using a two-tailed, paired student’s t-
test as performed by MS Excel, with a p-value of < 0.05 considered significant.  
EC50 values were obtained following variable-slope concentration-response 
analysis using log-transformed concentration and normalized response as 
performed by GraphPad Prism software (v 5.00, GraphPad Software, Inc., San 
Diego, California, USA). 
 
LDH. Cell death was also estimated in C6 cells by measuring the leakage of 
lactate dehydrogenase (LDH) into the culture medium as an indicator of plasma 
membrane damage.  C6 cells were plated at 1 x 105/ml in 96-well plates at 100 Vl
per well and allowed to attach overnight.  Prior to dosing, the medium was 
replaced with serum-free media, as serum contains LDH which can increase the 
background absorbance values in the assay. Cells were dosed with crude methanol 
extract from Parksville-A (AVM-positive) and Potato Creek-B (AVM-negative), 
at 3.125, 6.25, 12.5, 25, 50, and 100 mg/ml.  Control (no addition), vehicle control 
(methanol only), and positive control (methanol plus 1% Triton X-100 to lyse 
cells) groups were also included.  All doses were added in 1 Vl volumes (1% of 
total volume in well).  Following exposure for 24 h, the supernatant was collected, 
centrifuged at 5000 rpm for 10 min to remove cellular debris, and analyzed for the 
presence of LDH by the Takara LDH Cytotoxicity Detection Kit (Takara Bio Inc, 
Japan).  This kit measures LDH activity by measuring the reduction of NAD to 
NADH/H by the LDH-catalyzed conversion of lactate to pyruvate.  The reduced 
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NADH/H is then used in the reduction of the tetrazolium salt INT to formazan by 
diaphorase.  The reduced formazan product, a red dye, was quantified by 
measuring the absorbance on a NOVOStar microplate reader at 485nm.  
Background absorbance (media only) was subtracted from all values and percent 
cytotoxicity was calculated as [(experimental value – vehicle control)/(positive 
control – vehicle control)] x 100.   Triplicate wells from each treatment were 
averaged.  The assay was performed three times with different culture 
preparations and average means from the independent tests were compared using 
a two-tailed, paired student’s t-test as performed by MS Excel, with a p-value of  
< 0.05 considered significant.  EC50 values were obtained following variable-
slope concentration-response analysis using log-transformed concentration and 
normalized response as performed by GraphPad Prism software. 
 
Apoptosis Assays   
C6 cells were examined for apoptosis by two methods: (1) examining cell 
surface expression of phosphatidylserine (PS) and (2) measurement of caspase-3 
activity.  PS is a phospholipid normally associated with the cytoplasmic side of 
the cell membrane which is translocated to the outer leaflet of the membrane 
during apoptosis (Vermes et al., 1995).  Annexin V is a Ca2+-dependent 
phospholipid-binding protein with high affinity for PS, and when labeled with a 
fluorophore can be used to identify apoptotic cells by binding to exposed PS on 
the outer leaflet.   Caspases are a family of proteases that mediate the events 
associated with apoptosis.  Caspase-3 is an effector caspase that functions in cell 
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disassembly (Thornberry and Lazebnik, 1998) and its activity can be measured as 
an indicator of apoptotic cell death (Gurtu et al., 1997). 
C6 cells were plated at ~5 x 105/ml in 6-well plates at 2 ml per well and 
allowed to attach overnight.  Cells were exposed to crude methanol extracts from 
Potato Creek-A (AVM-negative), Woodlake and Parksville-B (AVM-positive) at 
12.5 and 50 mg/ml, as well as a vehicle control (methanol), harvested at 4, 8, and 
24h exposure, and washed once in cold phosphate buffered saline (PBS).  Ten 
percent of the cell suspension was used for the Annexin V assay and the 
remaining 90% for the caspase assay.  For the Annexin V assay, cells were then 
stained with fluorescein isothiocyanate (FITC)-labeled Annexin V and propidium 
iodide (PI) using the Vybrant Apoptosis Assay Kit #3 (Invitrogen, Carslbad, 
California, USA). Briefly, cells were washed once in cold PBS, re-suspended in 
annexin-binding buffer (10 mM HEPES, 140 mM NaCl2, 2.5 mM CaCl2, pH 7.4) 
to ~1 x 106 cells/ml, and stained with 5Vl of FITC annexin V and 1 Vg/ml of PI at 
room temperature for 15 minutes.  Cells were analyzed on a Coulter EPICS XL 
flow cytometer immediately following incubation with excitation at 488 nm and 
emission wavelengths of 525 nm and 635 nm for FITC and PI, respectively.  Cells 
showing only background fluorescence were determined to be live cells, FITC 
positive and PI negative cells were early apoptotic, and cells positive for both 
FITC and PI were late apoptotic or dead.   Three independent experiments were 
conducted and the percentages of dead (PI+) and apoptotic (FITC+/PI-) cells were 
compared by a repeated-measures one-way ANOVA followed by Tukey’s 
multiple comparison test as performed by GraphPad Prism software.  Due to 
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insufficient extract quantity only two replicates could be produced with the 
Parksville-A 50 mg/ml dose and it was not included in the statistical analysis.   
To determine caspase activity, the cells were diluted in PBS to equivalent 
cell densities for all samples, centrifuged, and pellets stored at -80°C until 
analysis.  Caspase activity was analyzed using the EnzChek Caspase-3 Assay Kit 
#1 (Invitrogen).  The principle of this kit is the caspase activated cleavage of the 
7-amino-4-methylcoumain-derived substrate Z-DEVD-AMC.  Upon cleavage, 
this substrate yields a blue fluorescent product that can be measured as an 
indicator of caspase activity in the sample.  Briefly, each pellet was re-suspended 
in cell lysis buffer and subjected to one freeze-thaw cycle to lyse cells.  Following 
centrifugation, 50 Vl of supernatant was transferred to individual wells of a 96-
well plate. 50 Vl of lysis buffer was used as a background control. 50 Vl of
substrate solution (0.2 mM Z-DEVD-AMC substrate; 10 mM dithiothreitol; 20 
mM PIPES; 4 mM EDTA; 0.2% CHAPS) was added to each sample and control 
well and incubated 30 min at room temperature in the dark.   Fluorescence was 
measured using a NOVOStar plate reader with excitation at 360 ±10 and emission 
detection at 450±10 nm.  Background fluorescence (lysis buffer control wells) 
was subtracted from each experimental value.  Three independent experiments 
were conducted and average fluorescence was compared among treatments by a 
repeated-measures one-way ANOVA followed by Tukey’s multiple comparison 
test as performed by GraphPad Prism software.  
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Cytoskeletal Staining and Morphological Observations 
F-actin. C6 cells were plated on poly-l-lysine coated coverslips at 1 x 105
cells/ml and allowed to attach overnight.  Cells were dosed with Potato Creek-A 
(AVM-negative) and Woodlake (AVM-positive) crude methanol extracts at 12.5 
mg/ml, as well as vehicle control (methanol only).  Following exposure at 0, 1, 2, 
4, 8, and 24 h, coverslips were washed twice in PBS, fixed in 3.7% formaldehyde 
for 10 min at room temperature, and permeabilized with 0.1% Triton X-100 for 3 
min at room temperature.  After two PBS washes, cells were stained with 
phalloidin (Oregon Green® 488 phalloidin, Invitrogen) plus 1% bovine serum 
albumin for 20 min.  DAPI (4’,6-diamidino-2-phenylindole) (0.25Vg/ml) was 
added and incubated 5 min.  Slides were washed twice in PBS and mounted on 
glass slides with Fluoromount G.  Fluorescence, phase contrast, and differential 
interference contrast images were taken on an Olympus BX51 microscope with an 
Olympus DP70 digital camera (Olympus America, Inc., Central Valley, 
Pennsylvania, USA). 
 
Tubulin. C6 cells were plated onto poly-l-lysine coated coverslips at 1 x 105
cells/ml and allowed to attach overnight.  Cells were dosed with AVM-negative 
(Potato Creek-A, Potato Creek-B) and AVM-positive extracts (Woodlake and 
Parksville-A) at 12.5 mg/ml, as well as vehicle control (methanol).  Following 
exposure for 0, 1, 2, 4, 8, and 24 h coverslips were washed twice in PBS, fixed in 
4% paraformaldehyde 5 min at room temperature (RT), washed twice in PBS, and 
permeabilized with 100% methanol (-20°C) for 5 min.  Coverslips were then 
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washed twice in PBS and incubated with 5% normal goat serum (Vector 
Laboratories, Inc., Burlingame, California, USA) in PBS for 45 min at 4°C, then 
incubated overnight at 4°C with primary antibody (monoclonal mouse anti-\-
tubulin, Sigma-Aldrich, St. Louis, Missouri, USA) at 1:400 in PBS.  The 
following day coverslips were washed twice in PBS and incubated 1h at RT with 
secondary antibody (anti-mouse IgG-FITC produced in goat, Sigma-Aldrich), 
washed twice in PBS, and stained with DAPI at 0.25 Vg/ml for 5 min at RT in the 
dark.  After a final PBS wash coverslips were mounted onto glass slides with 
Fluoromount G.  Fluorescence, phase contrast, and differential interference 
contrast images were taken on an Olympus BX51 microscope on an Olympus 
BX51 microscope with an Olympus DP70 digital camera. 
 
Cell Cycle Analysis by Flow Cytometry 
Cell cycle analysis was conducted by measuring the DNA content of cells 
stained with propidium iodide. C6 cells were plated at ~5 x 105/ml in 6-well 
plates at 2 ml per well and allowed to attach overnight. Cells were exposed to 
vehicle control (methanol) and all AVM-negative and AVM-positive extracts 
(Table 1).  In addition, cells were exposed to triethyltin bromide (97%, Acros 
Organics, New Jersey, USA) at 1.0, 5.0, 10.0, 20.0 and 50.0 VM, dissolved in 
methanol.  Following exposure at 4, 8, and/or 24 h, cells were harvested with 
trypsin-EDTA (supernatant was also collected to include any detached cells), 
pelleted by centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70% 
ethanol overnight at -20°C.  Cells were then pelleted (3500 rpm, 5 min, room 
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temperature) and stained with 10 Vg/ml propidium iodide in PBS containing 10 
Vg/ml RNase for 1 h at room temperature in the dark.  Flow cytometry analysis 
for cell cycle distribution was conducted on a Coulter EPICS XL with excitation 
at 488 nm and an emission wavelength of 635 nm.  A minimum of 10,000 cells 
were counted.  The percentage of cells in G1, S, and G2/M phases were estimated 
using Multicycle software (Phoenix Flow Systems, San Diego, California, USA).  
Three independent experiments were conducted and the percentages of cells in 
each phase were compared by a repeated-measures one-way ANOVA followed by 
Tukey’s multiple comparison test as performed by GraphPad Prism software.  
 
Results
Cytotoxicity Assays 
 Both Potato Creek-B and Parksville-A extracts reduced MTT conversion 
in a concentration-dependent manner for all cell lines (Figure 3), with complete 
cell death occurring at the highest concentration (100 mg/ml).   Direct comparison 
of response to Potato Creek-B and Parksville-A extracts at each concentration 
revealed few significant differences (Figure 3).  Calculated EC50 values (Table 6) 
did not differ significantly between the AVM-positive and AVM-negative 
extracts for C6 and PC-12 cells, but EC50’s for Parksville-A were significantly 
lower than Potato Creek-B for N2a and QNR/D cells.  N2a cells were the most 
sensitive cell line tested, with the lowest EC50 values for both extracts.  LDH 
release in C6 cells was also induced in a concentration-dependent manner, with 
cytotoxicity reaching a plateau at approximately 90% at 25 mg/ml (Figure 4). 
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Figure 3.  Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol 
extracts on cytotoxicity of C6, PC-12, N2a, and QNR/D cell lines as determined 
by the MTT assay.  Data are expressed as a percentage of viable cells relative to 
vehicle control (methanol only), with each point representing mean ± SEM of 
three or four independent experiments.  Asterisks (*) signify a significant 
difference (p < 0.05) between the Potato Creek and Parksville extract for that 
concentration. 
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Figure 3.  Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol 
extracts on cytotoxicity of C6, PC-12, N2a, and QNR/D cell lines as determined 
by the MTT assay.  Data are expressed as a percentage of viable cells relative to 
vehicle control (methanol only), with each point representing mean ± SEM of 
three or four independent experiments.  Asterisks (*) signify a significant 
difference (p < 0.05) between the Potato Creek and Parksville extract for that 
concentration (Continued). 
QNR/D 
N2a 
*
* *
*
*
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Table 6.  Effective concentrations of crude extract that elicit half-maximal 
viability (EC50) for each cell line following exposure for 24 h, as measured by the 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) reduction 
assay or the lactate dehydrogenase (LDH) assay. 
 
Crude Extract EC50 (mg/ml) (mean ± SE) 
 
Cell line 
 
Potato Creek-B 
(AVM-negative) 
 
Parksville-A 
(AVM-positive) 
MTT 
 C6 
 PC-12 
 N2a 
 QNR/D 
 
LDH 
 C6 
 
18.15 ± 1.03 
24.55 ± 1.06  
 4.52 ± 1.08 
17.30 ± 1.09 
 
11.92 ± 1.12 
 
17.59 ± 1.13 
25.32 ± 1.08 
 2.51 ± 1.09* 
 9.13 ± 1.17* 
 
14.50 ± 1.11 
* Significantly different from corresponding Potato Creek-B value, p< 0.05. 
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Figure 4.  Effect of Potato Creek-B (]) and Parksville-A (^) crude methanol 
extracts on cytotoxicity of C6 cells as determined by the LDH assay.  Data are 
represented as percent cell death, with each point representing mean ± SEM of 
three independent experiments.  Asterisks (*) signify a significant difference (p < 
0.05) between the Potato Creek and Parksville extract for that concentration. 
 
The calculated LDH EC50 values (Table 6) for Parksville-A and Potato Creek-B 
were not significantly different.   
 Cell morphology was also noted at 4 and 24 h after exposure to the 
extracts in these experiments.  In all cells lines the two high doses of extract 
contained large amounts of debris which obscured the cells and prevented any 
reliable observations.  At the lower doses, a slight loss of cellular processes and 
increased rounding was noted in varying degrees with PC-12, N2a, and QNR/D 
cells in a concentration-dependent manner.  This effect was observed in cells 
*
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exposed to both extracts, with the Parksville-A extract causing slightly greater 
changes in morphology but not being markedly different from Potato Creek-B.  A 
more pronounced rounding effect was seen in C6 cells and was consistently 
observed at all concentrations of the Parksville-A extract but not in the Potato 
Creek-B extract.  Small blebs could be seen on the cell surface of these rounded 
cells and it was hypothesized that these cells may be undergoing apoptosis.  To 
test this hypothesis C6 cells were examined for markers of apoptosis and changes 
in cell morphology were also further explored by cytoskeletal staining, as 
described below. 
 
Apoptosis Assays  
 To determine if the cell death observed in the cytotoxicity assays could be 
attributed to apoptotic mechanisms, C6 cells were exposed to AVM-positive 
(Parksville-A, Woodlake) and AVM-negative (Potato Creek-A) extracts and 
examined for markers of apoptosis. Cell surface expression of phosphatidylserine 
was measured using FITC-Annexin V, with propidium iodide used to distinguish 
cells in late apoptosis or necrosis.  The percentage of apoptotic cells (FITC+/PI-)
in populations exposed to AVM-negative and AVM-positive extracts did not 
differ significantly from control populations at any time point and consisted of a 
very small fraction of the total cell population (<2%).  The percentage of dead/late 
apoptotic cells (PI+) did not differ from control populations at the low dose of any 
extract, nor did it change over time.  However, the high dose of Potato Creek-A 
and Woodlake extracts induced a significant rise in PI+ cells at 24 h (Figure 5).   
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The Annexin V assay is unable to differentiate cells present in late apoptosis or 
necrosis, since both populations will stain with PI and FITC.  Therefore, while 
there is an increase in the number of dead cells in the population with the high 
dose of extract, it is not clear by which mechanism these cells died.  Since the 
percentage of FITC+/PI- cells remained low throughout the experiment and did 
not differ between samples it is reasonable to assume that the majority of the dead 
cells did not undergo apoptosis. 
 As a second measure of apoptosis, caspase-3 activity was monitored in C6 
cells at 4, 8, and 24 h after exposure to these extracts.   Potato Creek-A and 
Woodlake extracts both resulted in decreased caspase activity compared to control 
populations at 8 and 24 h with the high dose (50 mg/ml) (Figure 6).   No other 
significant differences were observed.  The decrease in caspase activity seen at 
the high doses of extracts may be due to increased cell death in these populations, 
as was observed in the Annexin assay.  Cell death was not preceded by an 
increase in caspase activity.  Taken together, these data indicate that neither the 
AVM-positive nor AVM-negative extracts significantly induce apoptosis in C6 
cells at the concentrations and time points examined. 
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Figure 5.  Dead/late apoptotic C6 cells as indicated by staining with propidium 
iodide following exposure to crude methanol extracts at 12.5 and 50 mg/ml for 4, 
8, or 24 h.  Data represent means ± SEM for 3 independent experiments. Asterisk 
(*) indicates significant difference (p < 0.05) from control.   
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Figure 6.  Caspase-3 activity in C6 cells following exposure to crude methanol 
extracts at 12.5 and 50 mg/ml for 4, 8, or 24 h.  Data represent means ± SEM for 
3 independent experiments. Asterisk (*) indicates significant difference (p < 0.05) 
from control. 
 
Cytoskeletal Staining and Morphological Observations 
 To further investigate the morphological changes noted in the cytotoxicity 
assays, C6 cells were exposed to Potato Creek-A and Woodlake extracts as well 
as vehicle control for 0, 1, 2, 4, 8, and 24 h, stained for F-actin and \-tubulin and 
viewed under fluorescent and light microscopy.  Control cells varied in 
morphology from flat, polygonal cells with no or varying numbers of processes to 
elongated bipolar cells.  Phalloidin staining revealed organized microfilament 
networks in the majority of cells, consisting of parallel bundles of filaments 
(Figure 7).  Spiky filopodia were seen protruding from the cell surface of many  
* *
*
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Figure 7.  Phase contrast and fluorescent images of C6 cells exposed to vehicle 
control (methanol) for 4 h and stained to visualize F-actin (green) and DNA 
(blue).  Organized parallel bundles (A) and spiky filopodia (B) were present.  
Rounded, mitotic cells with intense actin staining (C) and condensed 
chromosomes (D) were also observed. 
 
B
C
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cells (Figure 7).  A small number of rounded cells were also present with intense 
actin staining, especially at the periphery (Figure 7).  Parallel DAPI staining 
revealed condensed chromosomes in the nuclei of these rounded cells, indicating 
these cells were undergoing mitosis (Figure 7).  Control cell morphology did not 
change during the 0-8 h time points, but the percentage of elongated, bipolar cells 
was greatly increased at 24 h and the cell density was also increased (Figure 8).  
Tubulin staining revealed normal, organized microtubule networks in interphase 
cells and normal spindle apparatus in mitotic cells (Figure 9). 
 Cells exposed to Potato Creek-A extract did not appear to differ from 
control cells in morphology, microfilament or microtubule organization, or in the 
percentage of cells undergoing cell division (Figures 8, 10, 11).  However, cells 
treated with Woodlake extract experienced an increase in the proportion of 
rounded cells beginning as early as 1 h after exposure and continuing through 24 
h (Figure 8).  DAPI staining revealed condensed chromosomes in the nuclei of 
these cells, but unlike control and Potato Creek-B extract treated cells the 
chromosomes were consistently observed only in the beginning stages of mitosis 
and did not appear to move past prophase (Figures 12, 13).  F-actin organization 
in interphase cells appeared to be normal (Figure 12), with the exception of the  
24 h time point in which few cells remained in the normal morphology and those 
that had not yet rounded had less organized parallel bundles.  In addition, fewer 
processes were seen in cells at the latter time points and there was an increase of 
the amorphous actin concentrations at the cell periphery (Figure 12), which may 
represent processes retracting as cells began to round.  Tubulin staining revealed  
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 Control                     Potato Creek 10-14                Woodlake         
Figure 8.  Phase contrast images of C6 cells exposed to vehicle control (methanol) 
and crude methanol extracts from an AVM-negative (Potato Creek-A) and AVM-
positive (Woodlake) site.  
1h 
2h 
4h 
8h 
24h 
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Figure 9.  Fluorescent images of C6 cells exposed to vehicle control (methanol) 
for 4 h and stained to visualize microtubules (green) and DNA (blue).  Normal 
mitotic spindles (arrows) and chromosomes (arrowheads) can be seen in various 
stages of mitosis. 
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Figure 10.  Phase contrast and fluorescent images of C6 cells exposed to crude 
methanol extract from an AVM-negative site (Potato Creek-A) for 4 h.  Cells 
were stained to visualize F-actin (green) and DNA (blue).  Mitotic cells can be 
seen dividing (arrows). 
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Figure 11.  Fluorescent images of C6 cells exposed to crude methanol extract 
from an AVM-negative site (Potato Creek-A) for 4 h and stained to visualize 
microtubules (green) and DNA (blue).  Normal mitotic spindles (arrows) and 
chromosomes (arrowheads) can be seen in various stages of mitosis. 
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Figure 12. Phase contrast and fluorescent images of C6 cells exposed to crude 
methanol extract from an AVM-positive site (Woodlake) for 4 h.  Cells were 
stained to visualize F-actin (green) and DNA (blue).  Rounded cells (arrows) have 
condensed chromosomes and are thought to be present in early mitosis.  
Amorphous accumulations of actin (arrowhead) at the cell periphery may 
represent processes retracting as cells round. 
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Figure 13. Fluorescent images of C6 cells exposed to crude methanol extract from 
an AVM-positive site (Woodlake) for 4 h and stained to visualize microtubules 
(green) and DNA (blue).  Cells are uniformly present in prophase or 
prometaphase as condensed chromosomes can be seen (arrowheads), but there is 
no corresponding mitotic spindle formation (arrows).  
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normal microtubule networks in interphase cells but the normal spindle apparatus 
was absent or poorly defined in the majority of mitotic cells (Figure 13).   Normal 
spindle asters could be seen in some cells at the earlier time points (1 and 2 h post 
exposure), but at 4, 8, and 24h the majority of mitotic cells contained no visible 
spindle apparatus and no clear organization of microtubules (Figure 13).   Taken 
together, the cytoskeletal stains suggest the Woodlake extract slows or blocks 
progression from prophase to metaphase.  An additional AVM-positive 
(Parksville-A) and AVM-negative (Potato Creek-B) extract were subsequently 
tested on C6 cells and stained for tubulin at 4, 8, and 24 h.  Cells exposed to 
Potato Creek-B did not differ from control cells. Parksville-A induced a similar 
effect to Woodlake, with an increase in rounded, mitotic cells and an absence of 
spindle microtubules. 
 
Cell Cycle Analysis 
 To further investigate the potential mitotic block revealed with the 
cytoskeletal staining, a cell cycle analysis was conducted on several extracts from 
both AVM-positive and AVM-negative sites.  C6 cells were exposed to the 
extracts at 12.5 and 50 mg/ml for 4, 8, and 24 h and the percentage of cells in G1,
S, and G2/M was determined by flow cytometry.  Percentages of cells in each 
phase are displayed in Table 7 (AVM-negative) and Table 8 (AVM-positive) and 
representative histograms are shown in Figures 14 and 15.  AVM-positive extracts 
consistently produced an increase in the percentage of cells in S-phase or G2/M 
phase compared to control populations, and a corresponding decrease of cells in 
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G1. The high dose (50 mg/ml) generally resulted in an increase in S-phase cells, 
while the low dose (12.5 mg/ml) produced an increase of cells in G2/M.  This 
increase could be seen as early as 4 h, and with the high dose did not change at 
the 8 or 24 h time points.  At the low dose, depending on the extract, the 
percentage of cells in G2/M that were initially increased at 4 h either continued to 
increase at 8 and 24 h (DeGray, Parksville-A) or decreased and returned to near 
control levels by 24 h (Woodlake, Parksville-B).    The presence of a broad sub-
G1 peak, most likely representing cellular fragments and debris in the high doses 
of extract, indicates an increase in cell death at these concentrations.   
 Cells exposed to extracts from AVM-negative sites at the low dose were 
not significantly different than control cell populations at any time point. The high 
dose of Potato Creek-A and Potato Creek-B produced a slight but not significant 
increase in the proportion of S-phase and G2/M cells at all time points.  The high 
dose of SCWMA extract cause a significant increase in the proportion of cells in 
G2/M phase at 4 and 8 h, but populations returned to near control levels by 24 h.    
 Because the cell cycle analysis revealed differences in the extracts of the 
AVM-negative and AVM-positive sites tested, additional extracts from one 
AVM-positive site and two AVM-negative sites were prepared and analyzed by 
this assay to determine if the results would remain consistent.  For these analyses 
cells were exposed to the extracts for four hours only, since this time point was 
adequate in detecting the cell cycle disruption in the initial tests and the effect was 
often lost at the later time points.  Results are shown in Table 9 and Figure 16.  
The AVM-positive extract (Petersburg) induced a significant increase of G2/M  
Table 7. Cell cycle distribution of C6 cells exposed to AVM-negative extracts from Potato Creek Embayment, South Carolina and the
Santee Cooper Wildlife Management Area (SCWMA), South Carolina and vehicle control (methanol) for 4, 8, or 24 h.
4 h 8 h 24 h
G1 S G2/M G1 S G2/M G1 S G2/M
Control
Potato Creek
A
12.5 mg/ml
50.0 mg/ml
Potato Creek
B
12.5 mg/ml
50.0 mg/ml
SCWMA
12.5 mg/ml
50.0 mg/ml
47.30 ± 4.88
46.73 ± 5.40
42.10 ± 7.16
50.83 ± 8.29
43.67 ± 5.97
47.40 ± 5.28
31.70 ± 5.01*
31.97 ± 3.10
32.27 ± 3.32
36.17 ± 6.13
30.87 ± 5.55
34.33 ± 5.06
32.47 ± 3.52
34.10 ± 6.24
20.73 ± 1.77
21.03 ± 2.27
21.73 ± 1.58
18.30 ± 2.99
22.00 ± 0.96
20.13 ± 2.03
34.17 ± 2.29*
59.33 ± 2.87
58.73 ± 2.63
53.37 ± 4.81
57.80 ± 2.43
54.60 ± 4.37
62.07 ± 2.23
36.10 ± 8.30*
28.97 ± 3.09
29.30 ± 4.06
26.27 ± 2.81
29.70 ± 3.75
25.90 ± 2.00
27.27 ± 3.29
28.77 ± 4.34
11.70 ± 0.96
12.00 ± 1.60
20.37 ± 2.34
12.47 ± 1.71
19.50 ± 3.02
10.70 ± 1.47
35.13 ± 6.91*
75.23 ± 2.76
69.83 ± 4.09
64.43 ± 4.17
67.70 ± 6.33
63.27 ± 6.89
75.23 ± 1.74
67.30 ± 2.07
18.10 ± 1.25
21.17 ± 2.04
22.83 ± 6.61
21.37 ± 2.65
22.77 ± 2.88
17.97 ± 0.62
13.80 ± 1.80
6.67 ± 1.56
9.03 ± 2.07
12.73 ± 2.70
10.90 ± 3.75
13.97 ± 4.02
6.80 ± 1.12
18.90 ± 2.69
* Significantly different from control value, p < 0.05.
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Table 8. Cell cycle distribution of C6 cells exposed to AVM-positive extracts from Parksville Cove (J. Strom Thurmond Lake), South
Carolina; Woodlake, North Carolina; DeGray Lake, Arkansas; and vehicle control (methanol) for 4, 8, or 24 h.
4h 8h 24h
G1 S G2/M G1 S G2/M G1 S G2/M
Control
Parksville-B
12.5 mg/ml
50.0 mg/ml
Woodlake
12.5 mg/ml
50.0 mg/ml
DeGray
12.5 mg/ml
50.0 mg/ml
Parksville-A
12.5 mg/ml
47.30 ± 4.88
33.07 ± 4.81*
29.57 ± 2.98*
27.83 ± 4.67*
26.90 ± 2.17*
19.67 ± 1.43*
25.27 ± 1.07*
20.00a
31.97 ± 3.10
31.47 ± 3.00
49.83 ± 5.23*
34.43 ± 3.16
49.43 ± 3.96*
36.80 ± 3.78
42.07 ± 1.85*
26.20
20.73 ± 1.77
35.47 ± 1.94*
20.63 ± 3.27
37.73 ± 1.75*
23.67 ± 1.78
43.57 ± 2.92*
32.67 ± 0.98*
53.80
59.33 ± 2.87
45.50 ± 3.94
28.67 ± 2.62*
38.00 ± 8.35*
26.53 ± 1.83*
10.20 ± 0.30*
15.97 ± 2.18*
15.30
28.97 ± 3.09
29.87 ± 2.71
50.13 ± 4.51
34.47 ± 8.29
49.43 ± 5.48
29.87 ± 2.37
48.67 ± 5.36
23.90
11.70 ± 0.96
24.67 ± 2.74
21.23 ± 2.28
27.53 ± 4.53*
24.10 ± 3.86
59.93 ± 2.02*
35.37 ± 4.62*
60.90
75.23 ± 2.76
64.00 ± 3.79
27.57 ± 2.23*
59.23 ± 2.34
26.20 ± 0.92*
10.03 ± 0.33*
20.33 ± 2.95*
32.60
18.10 ± 1.25
21.27 ± 2.02
48.17 ± 5.78*
20.77 ± 1.00
45.63 ± 5.15*
15.27 ± 1.16
34.53 ± 8.63
18.80
6.67 ± 1.56
14.73 ± 2.19
24.27 ± 3.63*
20.03 ± 1.56
28.20 ± 4.28*
74.73 ± 0.88*
45.13 ± 7.11*
48.60
aValues represent only one replicate and are therefore not included in statistical analysis.
* Significantly different from control value, p < 0.05.
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Figure 14.   Representative histograms of cell cycle distribution in C6 cells treated 
with crude hydrilla extracts from AVM-negative sites and analyzed 4, 8 and 24 h 
after exposure.  Total DNA content is measured as the intensity of propidium 
iodide fluorescence.  The experiment was repeated three times with similar 
results. 
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Figure 15.   Representative histograms of cell cycle distribution in C6 cells treated 
with crude hydrilla extracts from AVM-positive sites and analyzed 4, 8 and 24 h 
after exposure.  Total DNA content is measured as the intensity of propidium 
iodide fluorescence.  The experiment was repeated three times with similar 
results. 
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Table 9.  Cell cycle distribution of C6 cells exposed to AVM-positive (Petersburg 
Cove, South Carolina) and AVM-negative (Dens Swamp, South Carolina; Lake 
Istokpoga, Florida) extracts and a vehicle control (methanol) for 4h. 
 
G1 S G2/M 
Control 
 
Petersburg 
 12.5 mg/ml 
 50.0 mg/ml 
 
Dens Swamp 
 12.5 mg/ml 
 50.0 mg/ml 
 
Istokpoga 
 12.5 mg/ml 
 50.0 mg/ml 
 
58.33 ± 2.97 
 
36.80 ± 0.10* 
54.00 ± 4.51 
 
60.87 ± 1.37 
53.83 ± 1.02 
 
59.53 ± 1.43 
60.23 ± 0.79 
 
30.77 ± 2.59 
 
33.57 ± 2.84 
30.53 ± 0.84 
 
28.20 ± 1.11 
31.23 ± 1.19 
 
30.23 ± 2.28 
28.57 ± 1.77 
 
10.87 ± 1.22 
 
29.63 ± 2.94* 
15.47 ± 4.05 
 
10.93 ± 1.19 
14.90 ± 1.42 
 
10.23 ± 1.79 
11.20 ± 1.83 
 
*Significantly different from control value, p < 0.05. 
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Figure 16.  Representative histograms of cell cycle distribution in C6 cells treated 
with crude hydrilla extracts and analyzed 4 h after exposure.  Total DNA content 
is measured as the intensity of propidium iodide fluorescence.  The experiment 
was repeated three times with similar results. 
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phase cells at the low dose and did not differ from control populations at the high 
dose.  A large sub-G1 peak indicating cell death was also seen at the high dose.  
Neither AVM-negative extract induced changes in cell cycle distribution at the 
low dose, while one (Dens Swamp) induced a slight but not significant increase in 
G2/M cells at the high dose. 
 In an attempt to determine if similar cell cycle disruption could be seen in 
a known compound causing similar effects to AVM in vivo, and to better 
understand the dose-response for the cell cycle results, cells were exposed to a 
dilution series of triethyltin (TET).  Results are seen in Table 10 and Figure 17 
and are similar to those observed with the crude extracts.  At 1.0 VM, TET did not 
differ significantly from control values, although there was a slight increase in 
G2/M at 4 h with one replicate. At 5.0 VM, TET caused a significant increase of 
cells in G2/M that continued through 24 h. An increase in S-phase and G2/M cells 
resulted from 10 VM TET and did not change notably over the time points, similar 
to that observed in the high dose of AVM-positive extracts.  The highest 
concentrations of TET (20, 50 VM) caused a slight but not significant increase in 
S and G2/M cells at 4 h, with no subsequent changes at the later time points, 
leading to significantly more cells in S-phase than that of controls by 24 h. The 
sub-G1 peaks indicating cell death also increased with the higher doses.   
 
Table 10. Cell cycle distribution of C6 cells exposed to triethyltin for 4, 8, or 24 h.
4h 8h 24h
G1 S G2/M G1 S G2/M G1 S G2/M
Control
1.0 VM
5.0 VM
10.0 VM
20.0 VM
50.0 VM
47.30 ± 4.88
52.23 ± 3.23
41.07 ± 5.69
35.23 ± 6.69
53.57 ± 2.29
51.00 ± 2.02
31.97 ± 3.10
28.40 ± 1.82
35.93 ± 4.11
41.53 ± 10.13
35.83 ± 5.56
34.60 ± 0.50
20.73 ± 1.77
18.37 ± 3.43
22.97 ± 3.79
23.27 ± 6.12
10.60 ± 3.41
14.43 ± 2.10
59.33 ± 2.87
68.37 ± 1.64
33.93 ± 7.11*
32.30 ± 4.59*
55.87 ± 2.46
49.70 ± 1.82
28.97 ± 3.09
19.50 ± 0.58
29.37 ± 10.50
39.30 ± 7.90
29.00 ± 3.76
36.00 ± 0.50
11.70 ± 0.96
12.10 ± 1.95
36.70 ± 6.31*
28.43 ± 4.69
18.47 ± 2.74
14.37 ± 2.25
75.23 ± 2.76
80.03 ± 2.30
28.40 ± 4.92*
29.07 ± 3.54*
49.40 ± 1.67*
45.17 ± 2.02*
18.10 ± 1.25
14.77 ± 0.37
28.20 ± 3.43
40.27 ± 5.36*
32.87 ± 2.03*
41.10 ± 0.92*
6.67 ± 1.56
5.20 ± 1.93
43.37 ± 4.39*
30.63 ± 2.31*
17.73 ± 3.43
13.67 ± 1.48
* Significantly different from control value, p < 0.05.
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Control                                                              1.0 VM
5.0 VM 10.0 VM
20.0 VM 50.0 VM
Figure 17. Representative histograms of cell cycle distribution in C6 cells treated 
triethyltin and analyzed 4, 8, and 24 h after exposure.  Total DNA content is 
measured as the intensity of propidium iodide fluorescence.  The experiment was 
repeated three times with similar results. 
 
G1
S
G2/M
DNA Content DNA Content
DNA Content DNA Content
DNA Content DNA Content
650 650
650 650
650
650
C
el
lc
ou
nt
C
el
lc
ou
nt
C
el
lc
ou
nt
C
el
lc
ou
nt
C
el
lc
ou
nt
C
el
lc
ou
nt
0 0
0 0
0 0
96 
Discussion
AVM-positive extracts caused a significant disruption of the cell cycle in 
C6 cells.  At lower concentrations, the extracts seem to slow progression through 
mitosis, causing an increase of cells in G2/M at 4 h.  This effect is then either 
alleviated after 24 h, presumably at lower concentrations, or cells continue to 
accumulate in G2/M.  Higher concentrations cause a buildup of cells is S-phase as 
well as G2/M at 4 h, with no subsequent changes occurring through 24 h.  The 
high concentrations of AVM-positive extracts were also associated with an 
increase in cell death.  TET caused a similar cell cycle arrest.  Lower, sub-lethal 
concentrations of both TET and AVM-positive extracts caused an increase in 
G2/M phase cells while higher concentrations resulting in cell death induce more 
of an increase in S-phase cells.  The highest concentrations do not appear to 
significantly affect the cell cycle, most likely because these concentrations result 
in acute cell death (20 and 50 VM TET, 50 mg/ml Petersburg extract).  AVM-
negative extracts also caused a slight increase in G2/M cells, but were not nearly 
as efficient at inducing this effect as AVM-positive extracts, with only one extract 
(SCWMA) inducing a significant change in cell cycle distribution at only the high 
concentration.   
The cell cycle assay appears to be a useful tool in identifying extracts from 
AVM-positive sites, although it is unknown whether or not the cell cycle arrest is 
caused by the etiologic agent of AVM.  An increase in G2/M cells was also noted 
in C6 cells exposed to AVM-negative extracts, although the effect was 
consistently lower than that produced with AVM-positive extracts and all 
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populations were recovered by 24 h.   It is possible that some of the AVM-
negative extracts tested could have contained the AVM agent in small amounts.  
For instance, the SCWMA extract, which induced a significant G2/M arrest at 4 h, 
came from a site with no known history of AVM, but the vegetation had not been 
previously tested by in vivo bioassay to confirm that the AVM agent was not 
present.   The two extracts from Potato Creek, which had been previously tested 
by mallard bioassay and did not induce AVM lesions, also induced a very slight 
increase in G2/M cells.  It could be that these samples did contain low levels of 
the causative agent and that the cell cycle analysis is a more sensitive measure 
than in vivo assays.  The Stigonematalan cyanobacteria that is suspected to be the 
source of the AVM toxin was not present in the vegetation collected from AVM-
negative sites, as confirmed by microscopic analysis and PCR (Williams, unpubl. 
data).  However, despite the strong correlations between this cyanobacteria and 
AVM-positive reservoirs (Wilde et al., 2005) a direct causal relationship between 
this cyanobacterium and AVM has not yet been established and it is possible that 
this cyanobacterium is not involved.   If the etiologic agent of AVM was not 
present in the vegetation collected from the AVM-negative sites then the observed 
cell cycle arrest could be due to another unrelated compound present in the crude 
extract.  Another possibility is that the AVM toxin could be having an additive or 
synergistic effect with some other compound.  Isolation of the AVM toxin from 
the crude extract will be necessary to further evaluate these results. 
 Cell cycle arrest has been noted in at least one compound known to 
produce intramyelinic edema –TET.  Zucker et al. (1989) found that TET induced 
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a cell cycle block in G2/M at or above 5 VM in murine erythroleukemic cells after 
4 h of exposure.  Similar results were found in this study, with TET inducing 
increases in both G2/M and S-phase cells at 5 and 10 VM.  In addition, the TET 
derivative triethyltin(IV)lupinylsulfide hydrochloride, which was synthesized and 
tested as a potential anticancer drug, induced a 42% increase in G2/M cells at 24 h 
in HCT-8 human colon carcinoma cells (Barbieri et al., 2001).  The mechanism 
behind these effects has not been elucidated.   
 The increase in S-phase cells at higher concentrations of extract appears to 
coincide with the increase in cytotoxicity.  S-phase is the period of DNA synthesis 
and reports of S-phase arrest are less frequent than that of G2/M or G1 arrest in the 
literature on cell cycle disruption.  S-phase arrest or delay has been reported with 
compounds that inhibit DNA replication, such as camptothecin, as well as in cells 
that have been subjected to radiation (Paulovich and Hartwell, 1995; Shao et al., 
1997).   The authors of these studies suggest the existence of an S-phase 
checkpoint that may delay progression through this phase in response to DNA 
damage.  It is possible that the S-phase arrest seen at the higher doses of AVM-
positive extracts may be related to an effect on DNA replication, but further study 
will be needed to determine the mechanism involved. 
 Flow cytometry cannot distinguish between cells in G2 or mitosis, but 
DAPI staining revealed an apparent increase of cells with condensed 
chromosomes following AVM-positive extract exposure, suggesting that the cells 
are arrested in mitosis and not G2.  The mechanism behind this arrest is not clear 
and will require further study.  Cells appear to be arrested in prophase, after 
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chromosome condensation but before mitotic spindle assembly.  While a normal 
spindle assembly was observed in control cells and those treated with AVM-
negative extract, spindle microtubules were not observed in the majority of 
mitotic cells exposed to AVM-positive extracts.  It is not clear whether the 
absence of spindle microtubules is due to a disruption of normal spindle assembly 
or if the cells are arrested at a point prior to spindle formation.  Several 
compounds are known to prevent or disrupt the normal formation of the mitotic 
spindle, either by preventing microtubule polymerization (i.e. colchicine, vinca 
alkaloids, nocodazole) or stabilizing microtubules and preventing 
depolymerization (i.e. taxol) (Rieder and Palazzo, 1992; Johnson and Walker, 
1999).  However, these compounds generally tend to disrupt normal spindle 
organization and arrangement but do not prevent spindle assembly (Jordan et al., 
1992).  Colchicine and related compounds have been shown to completely inhibit 
formation of spindle microtubules when applied before nuclear envelope 
breakdown (NEB), but these cells typically progress through NEB into 
prometaphase where the chromosomes become dispersed throughout the 
cytoplasm (Rieder and Palazzo, 1992).  Moasser et al. (1999) observed a similar 
mitotic arrest to that seen in our study by the tyrosine kinase inhibitor PD173955.  
They observed cells that appeared to be arrested in prophase, with condensed 
chromatin but no spindle apparatus.  The mechanism behind this effect was not 
clear, but thought to be related to the inhibition of one or more protein kinases.   
The cell cycle arrest observed in our study could be due to a similar effect on 
kinase activity, or a number of other factors involved in cell cycle regulation.  
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Microtubules and microfilaments of interphase cells did not appear to be 
affected by either extract.  Other compounds that induce intramyelinic edema 
have not been fully evaluated for their effects on microtubules or other 
cytoskeletal components.  Zucker et al. (1989) did not examine effects on 
microtubules or the mitotic spindle in their study revealing G2/M phase arrest with 
TET, and no other literature is available on the effects of TET on microtubules.  
Chow and Orrenius (1994) and Marinovich et al. (1990) found no effects of TET 
on F-actin in rat thymocytes and human neutrophils, respectively.  Microfilaments 
did not appear to be affected by the extracts in our study at the applied 
concentration, but there is a possibility that higher doses may have had deleterious 
effects. 
If the observed cell cycle arrest is induced by the causative agent of AVM, 
it is unclear how that effect may relate to the in vivo consequences of 
intramyelinic edema.  The mechanisms of action of TET, hexachlorophene 
(HCP), and other compounds resulting in intramyelinic edema are not fully 
known (van Gemert and Killeen, 1998).  TET, HCP, and bromethalin have been 
shown to affect cellular respiration, as uncouplers of oxidative phosphorylation 
(Moore and Brody, 1961; Cammer and Moore, 1972; Aldridge et al., 1977; 
Kauppinen et al., 1988; van Lier and Cherry, 1988), and TET has been shown to 
affect calcium homeostasis in vitro in several cell lines (Ade et al., 1996; Viviani 
et al., 1996; Kauppinen et al., 1998; Jan et al., 2002; Jiann et al., 2002; Lu et al., 
2003). However, it is not yet clear how these effects may relate to the formation 
of vacuoles in the myelin sheath.   Both TET and HCP are known to bind directly 
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to myelin as well as affect levels of myelin basic protein, which is though to play 
a role in myelin compaction (O’Callaghan and Miller, 1989; Veronesi et al., 1991; 
Amacher and Schomaker, 1994; van Gemert and Killeen, 1998).   
As demonstrated in this study and elsewhere (Zucker et al., 1989), TET 
causes an arrest of cells in G2/M in vitro, but the mechanism has not been 
elucidated and it is not known whether similar effects would be observed on cells 
in vivo. Research on the in vivo effects of other anti-proliferative compounds is 
usually focused on the treatment of cancerous cells which are rapidly dividing.  
After development, most cells of the nervous system, including neurons and glia, 
are differentiated and post-mitotic.  Neural stem cells exist in the adult brain and 
can give rise to new neurons, astrocytes, and oligodendrocytes, but rapid 
proliferation of cells generally occurs only after injury (Gage, 2002).  The rapid 
proliferation of astrocytes in response to toxic insult or other injury is well 
documented, but there is conflicting evidence as to whether this astrogliosis 
occurs in intramyelinic edema (Tripeir et al., 1981; O’Callaghan and Miller, 1989; 
Freeman et al., 1994; van Gemert and Killeen, 1998).  Thomas et al. (1998) 
reported astrogliosis in one of three eagles examined with AVM in the original 
description of the disease, but no other reports of astrocyte involvement have been 
reported in AVM studies. 
The effect of TET on the cell cycle does not seem to be specific to a 
certain cell type, as erythroleukemic (Zucker et al., 1989) and glial cells (this 
study) are affected in a similar manner.  It is not clear whether or not similar 
effects of cell cycle arrest would have been seen in the other cell lines examined 
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for cytotoxicity in this study.  Morphological observations of these cells revealed 
a mild rounding effect evident in both AVM-positive and AVM-negative extracts, 
but it is not known whether this rounding represented mitotic cells or cells 
undergoing apoptotic or necrotic cell death.   
The C6 cell line is derived from a glioma and is astrocytic in origin, but 
the effect on C6 cells in this study may represent a general cytotoxic effect rather 
than a glial or astrocyte-specific toxicity.  Established cell lines can provide 
indications of general cytotoxic effects as well as effects on cell division, but 
effects on specific cell types are usually studied using primary cultures (Mead and 
Pentreath, 1998).  This is due to the fact that established cultures, being either 
transformed or developed from tumors, may no longer retain all of the original in 
vivo characteristics of that cell type (Zucco et al., 1998).  Astrocyte-specific 
toxicity is usually studied in primary cultures; and the expression of glial fibrillary 
acidic protein (GFAP), an intermediate filament specific to astrocytes, has been 
shown to be the most sensitive indicator of astrocyte-specific toxicity (Cookson 
and Pentreath, 1994).  C6 cells have been shown to respond similarly to primary 
astrocytes in cytotoxicity assays as well as measures of GFAP but only after 
pretreatment with dibutyryl cyclic AMP (Cookson et al., 1995).   
The involvement of astrocytes in intramyelinic edema is debated.  In vivo 
studies have generally found no apparent involvement of astrocytes, although one 
study did describe astrocytic swelling (van Gemert and Killeen, 1998). TET has 
been studied in vitro for its effects on GFAP expression in primary astrocytic 
cultures with conflicting results.  Two studies found that while TET induced cell 
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death in these cultures, GFAP expression was either not affected at cytotoxic 
concentrations (Mead and Pentreath, 1998) or decreased in parallel with 
cytotoxicity (Rohl et al., 2001), while another found an increase in GFAP 
expression at sub-cytotoxic concentrations (Richter-Landsberg and Besser, 1994).    
The other endpoints examined in this study – cytotoxicity and induction of 
apoptosis – did not provide significantly different results for the AVM-positive 
and AVM-negative extracts.  Both extracts resulted in a concentration-dependent 
cytotoxicity in all cell lines examined.  The AVM-positive extract (Parksville-A) 
was slightly more toxic to N2a and QNR/D cells than the AVM-negative (Potato 
Creek-B) extract, but it is important to remember that the extracts tested were in 
crude form and contained a large number of compounds associated with the 
vegetation and epiphytic communities present.  The concentrations were 
normalized based on the dry weight of extracted vegetation and therefore do not 
provide a measure of any bioactive compounds present. It is possible that the 
additional presence of the AVM causative agent in the Parksville-A extract was 
the source of the additional toxicity; but it is equally as possible that the 
Parksville-A extract contained more of the cytotoxic substance or substances 
associated with the Potato Creek-B extract.  These assays may be able to detect 
the AVM toxin in a more purified extract, and could be revisited when such 
extracts are produced. 
The mechanism of cell death associated with the extracts did not appear to 
differ between the AVM-positive (Woodlake, Parksville-A) and AVM-negative 
samples (Potato Creek-A) tested, and neither appeared to induce apoptosis at the 
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concentrations and time points examined.  The high doses of AVM-positive 
extracts appeared to induce a fairly acute necrotic cell death, as the number of PI 
stained cells in the Annexin assay and the size of the sub-G1 peak in the cell cycle 
assay increased with these doses up to 24 h.  These doses did not produce an 
increase in caspase activity or Annexin V binding prior to cell death and thus 
appear to have undergone necrosis.  Populations of cells exposed to the lower 
doses of AVM-positive extracts and the AVM-negative extracts did not have 
appreciable cell death by 24 h.  It is unclear what the ultimate fate of the cells 
blocked in G2/M may be. At lower doses of some extracts (SCWMA, Parksville-
B, Woodlake, Petersburg) the cell populations appear to recover by 24 h.  In 
extracts where there is a continued G2/M phase block at 24 h (Dens Swamp, 
Parksville-A), it is likely that these cells proceeded to undergo apoptotic or 
necrotic cell death at a later time point.  There are reports of both apoptotic and 
necrotic cell death following cell cycle arrest induced by other compounds in 
various cell lines (Fujikawa-Yamamoto et al., 1994; Subbegowda and Frommel, 
1998; Butler et al., 2000).  TET is known to induce apoptosis in primary 
oligodendrocytes, hippocampal and cortical neurons (Thompson et al., 1996; 
Stahnke and Richter-Landsberg, 2004), but the effects of other inducers of 
intramyelinic edema on the mechanism of cell death in vitro has not been 
evaluated.  Two other organotin compounds, triphenyltin and tributyltin, have 
been shown induce apoptosis in several cell lines at low concentrations but result 
in necrosis at higher doses (Stridh et al., 1999) with triphenyltin also inducing cell 
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cycle arrest in G2/M at concentrations shown to induce apoptosis (Chikahisa et al., 
1998).   
The cell cycle arrest as measured by flow cytometry analysis of DNA 
content appears to be a promising assay in the detection of the AVM toxin.  
However, it is not yet clear whether the mitotic block associated with the AVM-
positive extracts is in fact due to the AVM causative agent and further 
fractionation and clean up of the crude extracts is necessary to isolate the AVM 
toxin for future testing.  In future examinations with this assay, the 4 h time point 
may be sufficient to observe any significant results, as this time point appears to 
be the most sensitive in detecting the cell cycle disruption and as the activity 
associated with lower concentrations of extract is lost by 24 h.  This may be due 
to a decrease in cell division rate at the later time points, as Rouzaire-Dubois et al. 
(2000, 2004) have shown that C6 cell proliferation slows as cells approach 
confluency.  In addition, since the effects on the cell cycle observed in this study 
were concentration-dependent, a range of dosages should be included to minimize 
the chance of missing any possible activity.  
The extraction procedure developed in Chapter 2 (Wiley, 2007) coupled 
with the discovery of the cell cycle disruption observed here provide promising 
tools in the future study of AVM pathology and the search for the causative agent 
of this disease.    If the cell cycle assay can be validated as a means of detecting 
the AVM toxin it can then be used to guide toxin fractionation and isolation 
studies, provide an alternative to in vivo assays, and provide a model to begin 
investigating mechanism of action. 
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CHAPTER 4 
IN VIVO AND IN VITRO TOXICITY OF FRACTIONS PRODUCED FROM A 
CRUDE EXTRACT OF HYDRILLA VERTICILLATA AND ASSOCIATED 
EPIPHYTES COLLECTED DURING AN AVM EPIZOOTIC 
 
Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease affecting 
bald eagles (Haliaeetus leucocephalus), American coots (Fulica americana) and 
other birds in the southeastern U.S.   The cause of AVM is unknown, though it is 
suspected to be a biotoxin and has been linked to ingestion of aquatic vegetation.  
AVM is associated with a number of reservoirs in five southeastern states, and to 
date had been responsible for the deaths of over 100 bald eagles and thousands of 
coots (Wilde et al., 2005).   
 AVM is characterized and diagnosed by a spongy degeneration of the 
white matter of the central nervous system. Multiple vacuoles of varying severity 
are seen throughout the white matter of the brain and spinal cord, being 
particularly prominent in the optic tectum (Thomas et al., 1998).   Birds with 
AVM may display clinical signs of neurological impairment, such as difficulty in 
flying, swimming, and/or walking, but not all birds with AVM lesions display 
clinical signs, and clinical recovery has been documented despite the persistence 
of lesions (Larsen et al., 2002).   
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AVM has been linked to the ingestion of aquatic vegetation, with several 
studies demonstrating induction of AVM in laboratory animals after ingestion of 
aquatic vegetation (Hydrilla verticillata and associated epiphytes) collected 
during AVM epizootics (Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et 
al., 2005).  As demonstrated by Fischer et al. (2003), predators such as the eagle 
contract AVM by feeding on affected prey. 
 It is not yet clear what factor associated with the vegetation causes AVM, 
but researchers have linked the disease to an epiphytic cyanobacterium that grows 
on the plant material.  Hydrilla that induced AVM in a mallard laboratory study 
contained large quantities of a novel cyanobacterial species that covered 50-90% 
of the leaf surface area (Birrenkott et al., 2004).  Surveys of cyanobacterial and 
algal epiphytes revealed the consistent presence of this species, a previously 
unknown member of the order Stigonematales, at all known sites of AVM 
epizootics (Wilde et al., 2005).  The cyanobacterium was present in high 
abundance at AVM sites, and was not observed, or observed in low abundance, at 
control sites.  It has been hypothesized that this species is producing a neurotoxin 
responsible for AVM.  
 We have been successful at extracting the AVM toxin from vegetation 
collected during an AVM epizootic (Wiley, 2007, Chapter 2).  This study 
produced a crude methanol extract that induced AVM in laboratory mallards upon 
exposure by oral gavage.  This crude extract, along with several other extracts 
produced from various sites of AVM outbreaks, also induced cell cycle arrest in 
C6 glioma cells (Wiley, 2007, Chapter 3).  The in vitro effects could not be 
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directly attributed to the AVM toxin, as the extracts were still in crude form and 
may have contained a variety of bioactive compounds associated with the 
vegetation or the epiphytic communities present.  As well, extracts from 
vegetation collected at sites having no previous history of AVM also induced a 
mild cell cycle arrest.   
 The objectives of this study were to further fractionate a crude methanol 
extract to advance the isolation of the AVM toxin, as well as evaluate the 
effectiveness of the in vitro cell cycle assay at detecting the toxin.  Crude extract 
was produced from vegetation collected during an AVM epizootic by methods 
developed in Chapter 2 (Wiley, 2007). Several fractions covering a full range in 
polarity were then isolated from this crude extract by liquid-liquid extraction as 
well as C18 solid phase extraction (SPE), and evaluated for toxicity by an in vivo 
chicken bioassay and the in vitro cell cycle analysis.    
 
Materials and Methods
Preparation of Crude Extract  
Crude methanol extracts were produced using methods developed in 
Chapter 2.  Aquatic vegetation (Hydrilla verticillata and associate epiphytes) was 
collected from Woodlake, North Carolina 22 November 2005 during an AVM 
epizootic.  Control hydrilla was collected 14 October 2003 from Potato Creek 
Embayment, Lake Marion, South Carolina, a reservoir with no known history of 
AVM.  Hydrilla was lyophilized, blended to a coarse powder, and dry weight was 
recorded (Potato Creek, 605.4 g; Woodlake, 1121.1 g).  Dried, powdered 
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vegetation was loaded evenly into two, 2 L separatory funnels and sequentially 
extracted with hexanes, acetone and methanol (Fisher Chemical, HPLC grade, 
Fischer Scientific, Hampton, New Hampshire, USA).  Solvent was added to the 
vegetation until saturated (1-1.5 L of solvent per funnel) and the sample was 
mechanically extracted by shaking for five, 2 min periods over 1 h.  The extract 
was then allowed to drain, and the sample was rinsed with a final volume of 
solvent (0.5 L).  Drained solvents were pooled.  This process was then repeated 
with the next solvent.  Hexanes and acetone extracts were discarded.  The 
methanol extracts were filtered through 70 mm Whatman qualitative grade filter 
paper (Whatman, Inc., Florham Park, New Jersey, USA) to remove particulates, 
and solvent was removed by a rotary evaporator (Buchi Rotavapor, Buchi, Flawil, 
Switzerland) with a water bath set no higher than 28°C.  When dry, the extracts 
were re-suspended in the appropriate volume of methanol to a concentration of 10 
g vegetation/ml solvent, based on the initial dry weight of the vegetation.   Half of 
the Potato Creek crude extract was archived at -20°C for use in in vitro studies 
and half was stored at -20°C for the chick study.  One-third of the crude 
Woodlake extract was stored at -20°C for the chick study, of which 20% was 
archived for in vitro studies.  The remaining two-thirds of Woodlake crude extract 
was further fractionated as described below.   
 
Preparation of Extract Fractions 
 Woodlake crude extract was brought to 90% methanol with deionized 
water and extracted 10x with hexanes to remove chlorophylls.  Hexanes fractions 
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were pooled.  The aqueous methanol fraction was then centrifuged at 3500 rpm 
for 10 min to remove particulates.  The pellet was washed twice with 90% 
methanol.  Supernatants were pooled and split in half.  One-half of the 
supernatant was brought to 60% methanol and extracted 3x with methylene 
chloride.  The remaining half of the supernatant was dried by rotary evaporator 
and re-suspended in 100% HPLC water for C18 SPE.  Prior to running through 
the C18 column, the extract was filtered through 70 mm Whatman qualitative 
grade filter paper to remove a significant amount of particulates that did not re-
suspend in the HPLC water.  These particulates were re-suspended in 100% 
methanol and archived at -20°C for potential future testing.  The dissolved 
fraction was run through a C18 SPE column (Varian BondElut C18 SPE column, 
Varian, Inc., Palo Alto, California, USA) and eluted with HPLC water; 25% 
methanol; 50% methanol; 75% methanol; 100% methanol; acetone; methylene 
chloride; and hexanes (Figure 18).  All resulting fractions were concentrated by 
rotary evaporator and/or lyophilization and re-suspended to 10 g vegetation/ml 
solvent, based on the initial dry weight of the vegetation.  Twenty percent of each 
fraction was archived at -20°C for in vitro testing and the remaining 80% was 
stored at -20°C until use in the chick study. 
 
Crude Methanol Fraction
1/3 2/3
Crude Bring to 90% MeOH
Extract with Hexanes
Hexanes Aqueous MeOH
-Centrifuge
Particulates Supernatant
1/2 1/2
Bring to 60% MeOH C18 SPE Column
Extract with MeCl2 -C18 H2O
-C18 25% MeOH
-C18 50% MeOH
MeCl2 Aqueous -C18 75% MeOH
MeOH -C18 100% MeOH
-C18 Acetone
-C18 MeCl2
-C18 Hexanes
Figure 18. Fractionation of the crude methanol extract produced from vegetation collected from Woodlake, North Carolina during an
AVM epizootic. MeOH=methanol. MeCl2=methylene chloride.
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Chick Bioassay 
 Forty-two, nine-day-old chicks were obtained from the Clemson 
University Morgan Poultry Center and transported to Godley-Snell Research  
Center at Clemson University.  Chicks were banded with wing tags for 
identification and housed in a single-cage commercial brooder.  Food and water  
were provided ad libitum. Chicks were acclimated four days prior to initiation of 
the treatment period. 
 Chicks were randomly assigned to experimental groups, with three birds 
per group.  Treatments were administered by oral gavage three times a week for 
two weeks.  Dose volumes were based on body weight at the time of dosing, at 
0.00646 ml/g b.w. and 10 g hydrilla/ml.  This concentration is based on the 
concentration given to mallards developing AVM in a previous study (Wiley, 
2007, Chapter 3).    Birds were observed twice daily for any sign of neurological 
impairment or distress.  At the end of the two-week treatment period, birds were 
euthanized by CO2 asphyxiation.  Whole brains were removed, weighed, and 
fixed in 10% neutral buffered formalin.  Brains were evaluated for AVM lesions 
at the Southeastern Cooperative Wildlife Disease Study, Athens, Georgia by 
methods previously described (Fischer et al., 2003).  
 
Cell Bioassay 
C6 cells were obtained from the American Type Culture Collection 
(ATCC).  Cells were maintained at 37°C with 5% CO2 in Kaighn’s modification 
of Ham’s F12 medium with 2mM L-glutamine modified to contain 1.5 g/L 
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sodium bicarbonate and supplemented with 15% horse serum and 2.5% fetal 
bovine serum.  Cells were routinely passaged twice weekly and cells in passages 
5-30 were used in assays.  All cells were grown in the absence of antibiotics. 
 Cell cycle analysis was conducted by measuring the DNA content of cells 
with propidium iodide.  C6 cells were plated at ~5x105/ml in 6-well plates at 2 ml 
per well and allowed to attach overnight.  Cells were exposed to all fractions at 
12.5, 50, and 100 mg/ml, as well as a vehicle control (methanol).  Following 
exposure for 4 h, cells were harvested with trypsin-EDTA, pelleted by 
centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70% ethanol overnight 
at -20°C.  Cells were then pelleted (3500 rpm, 5 min, room temperature) and 
stained with 10 Vg/ml propidium iodide in PBS containing 10 Vg/ml RNase for 1h 
at room temperature in the dark.  Flow cytometry analysis for cell cycle 
distribution was conducted on a Coulter EPICS XL with excitation at 488 nm and 
an emission wavelength of 635 nm.  A minimum of 10,000 cells were counted for 
each sample.  The percentage of cells in G1, S, and G2/M phases were calculated 
using Multicycle software (Phoenix Flow Systems, San Diego, California, USA).  
The experiment was repeated with three independent culture preparations and the 
percentages of cells in each phase were compared by a one-way ANOVA 
followed by Tukey’s multiple comparison test as performed by GraphPad Prism 
software (v 5.00, GraphPad Software, Inc., San Diego, California, USA). 
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Results
Chick Bioassay 
 No clinical signs of neurological disease or other signs of impairment or 
distress were noted during the study and all chicks steadily gained weight, though 
there were differences in weight gain among treatment groups (Figure 19).  Birds 
dosed with Woodlake crude extract gained significantly less weight during the 
study than those dosed with Potato Creek crude extract, as well as those dosed 
with hexanes, particulates, C18 hexanes, and C18 50% MeOH fractions. 
No definitive AVM-type lesions were seen in the chick brains.  There 
were a few brains with mild white matter lesions, consisting of a low number of 
vacuoles located in the optic lobe, brainstem, cerebral white matter and/or 
cerebellar folia. These mild lesions were seen in one bird given Woodlake crude 
extract, two birds given the MeCl2 fraction, and one bird each given the hexanes, 
C18 H20, and C18 100% MeOH fractions.  The bird exposed to the Woodlake 
crude extract had non-definitive AVM-like lesions, with diffuse tiny vacuoles 
present throughout the outer white matter layer of the optic lobe (Figure 20).  
Inflammatory lesions were also present in six brains that were indicative of a viral 
infection, but not associated with AVM.  Brain slides are archived at the Marine 
Resources Research Institute, South Carolina Department of Natural Resources, 
Charleston, South Carolina, USA. 
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Figure 19.  Average weight gain of chicks by treatment group from the initiation 
of the study to euthanasia.  Data are represented as means ± SEM.  
(WL=Woodlake).  Asterisk represents significant difference from Potato Creek 
treatment, with a p-value of c 0.05. 
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Figure 20.  Mild white matter lesions in chickens exposed to a Woodlake crude 
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes; 
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH.  Vacuoles can be seen 
in various white matter tracts (arrows). 
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Figure 20.  Mild white matter lesions in chickens exposed to a Woodlake crude 
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes; 
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH.  Vacuoles can be seen 
in various white matter tracts (arrows) (Continued). 
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Figure 20.  Mild white matter lesions in chickens exposed to a Woodlake crude 
extract and fractions produced from that crude extract: (A) C18 H20; (B) Hexanes; 
(C); MeCl2; (D) MeCl2; (E) Crude; (F) C18 100% MeOH.  Vacuoles can be seen 
in various white matter tracts (arrows) (Continued). 
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Cell Bioassay 
 Significant cell cycle arrest in G2/M phase was observed in two fractions.  
The percentages of cells in each phase are shown in Figure 21.  The C18 100% 
MeOH fraction caused a significant 3-fold increase in G2/M cells at 100 mg/ml 
and a significant 2-fold increase at 50 mg/ml, with concomitant decrease of G1
cells.  The MeCl2 fraction caused a significant 3-fold increase in G2/M cells at 
12.5 mg/ml and a 2-fold, but not significant increase at 50 and 100 mg/ml.  There 
were no other significant differences from control populations. 
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Figure 21.  Cell cycle distribution of C6 cells exposed to fractions produced from 
the Woodlake crude extract at 100, 50 and 12.5 mg/ml and a vehicle control 
(methanol only).  Data represent means ± SEM for three independent 
experiments.  Asterisks represent significant difference from control, with a p-
value c 0.05. 
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Figure 21. Cell cycle distribution of C6 cells exposed to fractions produced from 
the Woodlake crude extract at 100, 50 and 12.5 mg/ml and a vehicle control 
(methanol only).  Data represent means ± SEM for three independent 
experiments.  Asterisks represent significant difference from control, with a p-
value c 0.05 (Continued). 
 
Discussion
The goal of this study was to fractionate the crude methanol extract in an 
attempt to further isolate the AVM toxin, thereby gaining more information on the 
physicochemical properties of the toxin as well as gaining further evidence that 
the cell cycle arrest observed with the crude extracts in Chapter 3 (Wiley, 2007) 
could be attributed to the toxin.  In vitro analysis revealed significant cell cycle 
12.5 mg/ml 
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arrest in two fractions of intermediate polarity: the MeCl2 fraction produced from 
liquid-liquid extraction and the 100% MeOH fraction produced from C18 SPE.  
Unfortunately, the presence of the AVM causative agent in these fractions could 
not be confirmed because the results of the chick bioassay were inconclusive.  
Mild white matter lesions were present in two of three chicks brains administered 
the MeCl2 fraction and one of three birds administered the C18 100% MeOH 
fraction.  However, mild lesions were also seen in one of three birds administered 
both the hexanes fraction and the C18 H20 fraction, which had no effect on the 
cell cycle.   
The crude extract produced from the vegetation resulted in mild white 
matter lesions in only one of three birds tested.  Therefore, the fact that the 
fractions did not produce definitive lesions is not likely due to the fractionation 
procedure but some other issue.  The fractionation procedure did efficiently 
isolate the toxic activity associated with the cell cycle arrest.  The MeCl2 fraction 
induced cell cycle disruption at the same concentration as the crude extract, which 
also significantly arrested the cells in G2/M at 12.5 mg/ml (Wiley, 2007, Chapter 
3), suggesting that the liquid-liquid fractionation did not result in a loss of 
toxicity.  Some toxicity associated with cell cycle arrest was lost with the C18 
SPE procedure, as the C18 100% MeOH fraction did not induce cell cycle 
disruption below 50 mg/ml.  This may due to the fact that the extract was re-
suspended in 100% water prior to running through the SPE column and a portion 
of the extract did not dissolve in this solvent.  Re-suspending the extract in 25-
50% methanol in water may work more efficiently for future procedures using 
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C18 columns.  Despite the observed in vitro effects, the effectiveness of the 
fractionation procedure at isolating the AVM toxin is unknown and will need 
future study. 
 Birds exposed to Woodlake crude extract had significantly lower weight 
gain on average than birds given Potato Creek extract.  Decreased weight gain in 
AVM-affected birds has not been previously noted in other AVM studies 
involving chickens (Lewis-Weis et al., 2004).  However, studies with triethyltin 
and hexachlorophene have reported decreased weight gain in rats and mallard 
ducklings exposed to concentrations producing intramyelinic lesions (Beirkamper 
and Valdes, 1982; Kung et al., 1988; Fleming et al., 1991).  Since the brain results 
were inconclusive, it is impossible to say whether or not the decreased weight 
gain in this group was due to exposure to the AVM toxin.  Several other treatment 
groups also had decreased weight gain compared to the Potato Creek group, 
including the aqueous methanol, C18 MeCl2 and C18 Acetone groups, but those 
results were not significant and these fractions did not produce any toxic effects in 
vitro.
There are several possible explanations for the inconclusive results 
obtained in this study, including insufficient toxin concentration in the extracted 
vegetation, an insufficient period of exposure, an inappropriate animal model, or a 
combination of these factors.  The vegetation extracted in this study was collected 
from Woodlake during an AVM epizootic in which large numbers of American 
coots were diagnosed with the disease (Wilde, unpubl. data).  However, the 
vegetation was not tested by mallard bioassay prior to this study to confirm AVM 
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toxin presence and it is possible that the toxin was no longer present at the time of 
our collections (or present but at a low concentration).  Coots are able to survive 
for several weeks after AVM lesion formation (Larsen et al., 2002), so the AVM-
affected birds that were observed on Woodlake during our collections could have 
been exposed to the causative agent weeks earlier.  Rocke et al. (2005) and Larsen 
et al. (2003) failed to induce AVM in laboratory mallards after exposure to 
hydrilla collected from Woodlake while affected coots were present.  There may 
be a short window of toxin production and persistence in these reservoirs that is 
not directly correlated with the presence of affected birds.  It is also possible that 
the toxic agent is not evenly distributed throughout the vegetation and the samples 
that were collected in these studies happened to contain low concentrations. 
 Another possible explanation for the inconclusive results in this study is 
that the exposure time was insufficient to produce effects.  Previous laboratory 
and field studies have shown that birds can develop lesions within two weeks of 
exposure to the causative agent of AVM, with five days being the earliest known 
onset.  However, this data was discovered only after the birds displayed clinical 
signs of AVM (Rocke et al., 2002; Wiley, 2007, Chapter 1) or after birds were 
euthanized due to unrelated reasons, as with the bird whose wing was broken in 
the mallard extract study (Wiley, 2007, Chapter 2).  The only laboratory study 
undertaken with the goal of exploring the onset of AVM lesion formation was not 
successful since none of the birds developed AVM (Wiley, 2007, Chapter 1).   
Therefore, it is not clear whether all birds developing AVM experience quick 
lesion onset after an acute exposure, or whether some birds may develop the 
130 
disease after more chronic, low level exposure to the causative agent.  Studies 
with triethyltin and hexachlorophene describe a concentration-dependent timing 
of vacuole formation in mice and rats in acute studies, with a single i.p. or i.v. 
injection and vacuole formation observed up to 30 h following exposure (Jacobs 
et al., 1977; Tripier et al., 1981).  Both acute and chronic experiments have been 
conducted with these chemicals, but the time of lesion formation in more chronic 
experiments has not been evaluated.     
 A final possibility concerning the absence of definitive AVM lesions may 
be that the chickens are not a suitable animal model for studying AVM toxicity. 
Chickens were selected as the animal model for this research due to their smaller 
body weight and lower tendency to regurgitate after gavage compared to adult 
mallards, which have been the standard animal model used in our laboratory.  
Chickens are also more readily available and easy to obtain than mallards.  Adult 
mallards were used as the animal model in the previous study involving the 
gavage of crude vegetative extract (Wiley, 2007, Chapter 2).  This study was 
successful at inducing AVM lesions in these birds, but required extensive 
preparation time due the large quantities of vegetation that had to be lyophilized 
and extracted.  In addition, mallards frequently regurgitated the administered 
material after gavage.  Although the birds did subsequently develop AVM lesions, 
it was felt that an animal model less apt to regurgitate would be more appropriate.  
Young chickens had been used successfully as animal models in a previous AVM 
study (Lewis-Weis at al., 2004), and it was thought that these birds would provide 
a suitable model for this research.  However, while Lewis-Weis et al. revealed 
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that chickens are susceptible to AVM, the relative sensitivity of chickens to the 
AVM agent compared to other birds is unknown.   
 Any or all of the above mentioned factors could be responsible for the 
failure to induce AVM lesions in the chicks.  Unfortunately there are still many 
unanswered questions concerning this disease and we can only speculate as to 
which variables may have played a role.  Although the fractionation procedure 
used in this study successfully isolated the in vitro toxicity associated with the 
extracts, these effects cannot be attributed to the AVM toxin due to the absence of 
definitive lesions in the chicks.  Further studies are therefore needed to validate 
both the fractionation procedure and the in vitro assay. 
It is recommended that future experiments should be conducted for at least 
four weeks, with vegetation that is first confirmed to contain the AVM toxin by 
mallard bioassay.  Although these measures will increase the time and cost 
involved for both extract preparation and the animal trials, they will help 
eliminate some of the frustrating questions that have arisen with this study.  The 
use of another animal model such as mallards should also be considered, although 
the problems associated with doing such a study with mallards (amount of 
vegetation, regurgitation concerns, and availability) will have to be taken into 
account.    
The potential benefits of a successful fractionation procedure and 
validated in vitro model to AVM research are undeniable.  Toxin isolation and 
characterization depend upon this research, as do mechanism of action studies.   
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Hopefully the results obtained in this study and the issues that have arisen in 
interpreting those results will aide future research efforts in this area. 
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CHAPTER 5 
ORAL ADMINISTRATION OF AN EXTRACT OF HYDRILLA 
VERTICILLATA CONTAINING THE ETIOLOGIC AGENT  
OF AVM TO A MOUSE MODEL 
 
Introduction
Avian vacuolar myelinopathy (AVM) is a neurological disease primarily 
affecting bald eagles (Haliaeetus leucocephalus) and American coots (Fulica 
americana) in the southeastern U.S.   The cause of AVM is unknown, though it is 
suspected to be a biotoxin and has been linked to ingestion of aquatic vegetation.  
AVM is associated with a number of reservoirs in five southeastern states, and to 
date had been responsible for the deaths of over 100 bald eagles and thousands of 
coots (Wilde et al., 2005).   
 AVM is characterized and diagnosed by a spongy degeneration of the 
white matter of the central nervous system. Multiple vacuoles of varying severity 
are seen throughout the white matter of the brain and spinal cord, being 
particularly prominent in the optic tectum (Thomas et al., 1998).   Birds with 
AVM may display clinical signs of neurological impairment, such as difficulty in 
flying, swimming, and/or walking, but not all birds with AVM lesions display 
clinical signs, and clinical recovery has been documented despite the persistence 
of lesions (Larsen et al., 2002).   
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AVM has been linked to the ingestion of aquatic vegetation, with several 
studies demonstrating induction of AVM in laboratory animals after ingestion of 
aquatic vegetation (Hydrilla verticillata and associated epiphytes) collected 
during AVM epizootics (Birrenkott et al., 2004; Lewis-Weis et al., 2004; Rocke et 
al., 2005).  As demonstrated by Fischer et al. (2003), predators such as the eagle 
contract AVM by feeding on affected prey. 
 It is not yet clear what factor associated with the vegetation is the source 
of AVM, but researchers have linked the disease to an epiphytic cyanobacterium 
that grows on the plant material.  Hydrilla that induced AVM in a mallard 
laboratory study contained large quantities of a novel cyanobacterial species that 
covered 50-90% of the leaf surface area (Birrenkott et al., 2004).  Surveys of 
cyanobacterial and algal epiphytes revealed the consistent presence of this 
species, a previously unknown member of the order Stigonematales, at all known 
sites of AVM epizootics (Wilde et al., 2005).  The cyanobacterium was present in 
high abundance at AVM sites, and was not observed, or observed in low 
abundance, at control sites.  It has been hypothesized that this species is 
producing a neurotoxin responsible for AVM.  
 The list of susceptible species is currently confined to birds, and in 
addition to bald eagles and coots, includes mallards (Anas platyrhynchos), ring-
necked ducks (Aythya collaris), buffleheads (Bucephala albeola), Canada geese 
(Branta canadensis), great-horned owl (Bubo virginianus), and killdeer 
(Charadrius vociferus).  Red-tailed hawks (Buteo jamaicensis) and domestic 
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chickens (Gallus domesticus) have also been shown to be susceptible in 
laboratory studies. 
 AVM lesions have never been confirmed in mammals during AVM 
epizootics, though there has been anecdotal evidence of possible clinical signs in 
a beaver (Castor canadensis) (Lewis-Weis et al., 2004).  Several mammals were 
collected during AVM outbreaks on J. Strom Thurmond Lake, a reservoir located 
on the South Carolina/Georgia border, over the last few years, including beavers, 
raccoons (Procyon lotor) and a gray fox (Urocyon cinereoargenteus).  Definitive 
AVM lesions were not found in their brain tissue, despite the fact that coot tissue 
was discovered in the stomach contents of one raccoon and the fox (Fischer et al., 
2006).   
There have been several laboratory studies to examine mammalian 
susceptibility to AVM.  Swine failed to develop lesions when fed AVM-affected 
coot tissue, though the authors note that the duration of exposure and quantity of 
ingested material may not have been sufficient to induce disease (Lewis-Weis et 
al., 2004).  Mice fed hydrilla collected during AVM events also failed to develop 
lesions (Rocke et al., 2005; Birrenkott, unpubl. data); however, these animals did 
not appear to consume much, if any, of the vegetation in at least one study 
(Birrenkott, unpubl. data).  It is also possible that the vegetation may not have 
contained the causative disease agent in sufficient quantities to induce disease.   
 Due to the potential health implications for humans consuming affected 
waterfowl or otherwise coming into contact with the AVM toxin, as well as the 
potential for mammalian wildlife to be affected, mammalian susceptibility to the 
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AVM toxin needs further exploration. We have recently been successful at 
extracting the AVM toxin from vegetation collected during an AVM epizootic 
(Wiley, 2007, Chapter 2).  This study produced a crude methanol extract that 
induced AVM in laboratory mallards upon exposure by oral gavage.  The current 
study utilized archived extract from the successful mallard study in an attempt to 
induce AVM in laboratory mice.  By delivering the known toxic extract by oral 
gavage, this study ensures that the mice are exposed to an active toxin in a 
concentrated form, giving a better indication of mammalian susceptibility than 
previous studies.   
In addition to administering the crude methanol extract, a portion of the 
extract was further fractionated and those fractions were tested by the mouse 
model as well as an in vitro assay.  Further fractionation of the crude extract and 
the development of an in vitro assay for detection of the AVM toxin would 
greatly benefit AVM research.  The crude extract had been previously shown to 
induce cell cycle arrest in C6 glioma cells (Wiley, 2007, Chapter 3), and the cell 
cycle assay is a potentially useful means of detecting the AVM toxin.  However, 
the cell cycle arrest could not be directly attributed to the AVM toxin as the 
extract was in crude form and may have contained a variety of bioactive 
compounds associated with the vegetation or the epiphytic communities present.  
Therefore, in the hopes of further validating the assay, all fractions produced from 
the crude extract were tested by the cell cycle assay in addition to the mouse 
model. 
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Materials and Methods
Preparation of Crude Extracts 
 Crude extracts were produced in a previous study (Wiley, 2007, Chapter 
2).  Briefly, aquatic vegetation (Hydrilla verticillata and associated epiphytes) 
was collected from an AVM-positive site (Parksville Cove, J. Strom Thurmond 
Lake, South Carolina, USA) and a control site with no previous history of AVM 
(Potato Creek Embayment, Lake Marion, South Carolina, USA) and presence or 
absence of the AVM causative agent was confirmed by an ad libitum mallard 
feeding study using half of the collected material (Wiley, 2007, Chapter 2).  The 
remaining half of the vegetation was extracted as follows.  Vegetation was 
lyophilized, blended into a coarse powder, and sequentially extracted using a 
series of solvents: hexanes, acetone, and methanol.  Extracts were filtered and 
concentrated, and ten percent was archived for future use.  The remaining 90% 
was used in a mallard gavage study to determine which extracts contained the 
AVM toxin.  Results from the study showed that the methanol extract contained 
the active toxin, as all three birds exposed to the extract developed white-matter 
lesions consistent with AVM.  The archived methanol extracts of control and 
AVM-positive hydrilla were used in the present study.  Prior to dosing, solvent 
was evaporated by N2 stream and extracts were re-suspended in a 90:10 solution 
of DI water:propylene glycol to a concentration of 10 g hydrilla/ml vehicle. 
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Preparation of Extract Fractions 
 The AVM-positive crude methanol extract was further fractionated for the 
present study (Figure 22).  A portion of the crude methanol extract was brought to 
90% methanol with deionized (DI) water and extracted 12x with an equivalent 
volume of hexanes to remove chlorophylls.  Hexanes fractions were pooled.   The 
aqueous methanol fraction was then centrifuged to remove particulates by 
spinning at 3600 rpm for 10 min.  The pellet was washed 3x with 90% methanol 
and supernatants were pooled.  The supernatant was brought to 60% methanol 
with deionized water and extracted 3x with methylene chloride.  Methylene 
chloride fractions were pooled.  Hexanes, methylene chloride, and aqueous 
methanol fractions were reduced by rotary evaporator, N2 stream, and/or 
lyophilizer and re-suspended in a 90:10 solution of DI water: propylene glycol to 
a concentration of 10 g hydrilla/ml vehicle.  Particulates were re-suspended in DI 
water to a concentration of 10 g/ml.   
 
Mouse Bioassay 
Nineteen male ICR mice (25-34 g, Harlan, Indianapolis, Indiana, USA) 
were received 4 April 2006 and housed three per cage by experimental group, 
with one extra mouse housed separately.  Individuals were identified by ear 
punch. Animals were acclimated for six days prior to treatment and received 
commercial feed and water ad libitum throughout the study.  The six experimental 
groups (three mice per group) consisted of the control and AVM-positive crude  
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 Crude Methanol Extract  
 
1/2           1/2  
 
Crude                         Bring to 90% MeOH  
 Extract with Hexanes 
 
Hexanes                         Aqueous MeOH 
 
-Centrifuge 
 
Particulates                             Supernatant 
 
Bring to 60% MeOH    
 Extract with MeCl2
MeCl2 Aqueous MeOH
 
Figure 22.  Fractionation of crude methanol extract containing the active AVM 
toxin.  Four fractions result: hexanes, particulates, methylene chloride (MeCl2), 
and aqueous methanol (MeOH). 
 
extracts, as well as the four fractions of the AVM-positive extract: hexanes, 
particulates, methylene chloride, and aqueous methanol.   
Extracts were delivered by oral gavage in five doses over a two-week 
treatment period.  Dose volumes were based on body weight at the time of dosing, 
corresponding to the mallard extract study (0.00646 ml/g b.w. at 10 g 
hydrilla/ml).  Mice were observed twice daily for signs of neurological 
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impairment or other abnormal behavior.  Due to the loss of two mice in the 
methylene chloride group after the first dose administration (see results), the 
nineteenth mouse (an extra) was placed in this group.  Since this mouse only 
received four doses, each dose was increased to give an equivalent amount as the 
other mice.  Mice were euthanized by CO2 asphyxiation at the conclusion of the 
two-week treatment period.  Brains were removed, weighed, and fixed in 10% 
neutral buffered formalin.  AVM diagnosis was conducted at the Southeastern 
Cooperative Wildlife Disease Study (SCWDS) by methods previously described 
(Fischer et al., 2003).  Liver, kidney, and gastrointestinal tracts were removed and 
archived at -20°C.  
 
Cell Bioassay 
C6 cells were obtained from the American Type Culture Collection 
(ATCC).  Cells were maintained at 37°C with 5% CO2 in Kaighn’s modification 
of Ham’s F12 medium with 2mM L-glutamine modified to contain 1.5 g/L 
sodium bicarbonate and supplemented with 15% horse serum and 2.5% fetal 
bovine serum.  Cells were routinely passaged twice weekly and cells in passages 
5-30 were used in assays.  All cells were grown in the absence of antibiotics. 
 Cell cycle analysis was conducted by measuring the DNA content of cells 
with propidium iodide.  C6 cells were plated at ~5x105/ml in 6-well plates at 2 ml 
per well and allowed to attach overnight.  Crude extracts were tested previously in 
Chapter 3.  Fractions of AVM crude extract were tested at 12.5, 50, and 100 
mg/ml.  Following exposure at 4 h, cells were harvested with trypsin-EDTA, 
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pelleted by centrifugation at 3500 rpm for 5 min, and fixed in ice-cold 70% 
ethanol overnight at -20°C.  Cells were then pelleted (3500 rpm, 5 min, room 
temperature) and stained with 10 Vg/ml propidium iodide in PBS containing 10 
Vg/ml RNase for 1h at room temperature in the dark.  Flow cytometry analysis for 
cell cycle distribution was conducted on a Coulter EPICS XL with excitation at 
488 nm and an emission wavelength of 635 nm.  The percentage of cells in G1, S, 
and G2/M phases were calculated using Multicycle software (Phoenix Flow 
Systems, San Diego, California, USA).  The experiment was repeated with three 
independent culture preparations and the percentages of cells in each phase were 
compared by a one-way ANOVA followed by Tukey’s multiple comparison test 
as performed by GraphPad Prism software (v 5.00, GraphPad Software, Inc., San 
Diego, California, USA). 
 
Results
No signs of neurological impairment were noted during the study.   Two 
mice (MeCl2 and particulate groups) were euthanized within 2 d of the first dose 
administration due to swollen right sides and general lethargy.  A third mouse 
(MeCl2 group) was found dead the day following the first dose administration.  
Two days following the second dose administration, another mouse (MeCl2
group) was found dead after appearing slightly lethargic the previous day.  All 
four of these mice appeared to have developed infections due to gavage error.  
Necropsy revealed that the esophageal tract was punctured during gavage, 
allowing the dose solution to enter the thoracic cavity. 
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 No white matter lesions characteristic of AVM were seen in any mouse 
brains.  However, in 10 of the 19 mice there was unusual focal vacuolization with 
low numbers of vacuoles within the hippocampus, usually in the molecular layer 
adjacent to the pyramidal cell layer (Figure 23) and occasionally in the pyramidal 
cell layer.  These vacuoles were seen in all experimental groups except the 
control, although the number of mice with vacuoles varied among the groups 
(Table 11).  Upon consultation with several pathologists, it was determined that 
these vacuoles may have been an artifact of formalin fixation, though this could 
not be confirmed and the fact that the lesions were not seen in control mice raises 
suspicions.  Brain slides are archived at the Marine Resources Research Institute, 
South Carolina Department of Natural Resources, Charleston, South Carolina, 
USA. 
Results of the in vitro cell cycle analysis are shown in Figure 24.  The 
MeCl2 fraction of the AVM crude extract caused a significant increase in the 
number of cells present in G2/M at 50 and 100 mg/ml.  A slight but not significant 
increase in G2/M cells was also seen in cells exposed to the hexanes fraction at 
100 mg/ml.  The control crude extract (tested in Chapter 3, Wiley, 2007), the 
particulate fraction and the aqueous methanol fraction did not induce cell cycle 
arrest. 
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Figure 23.  Light micrograph image of the hippocampus of a mouse gavaged with 
crude methanol extract from Parksville Cove, J. Strom Thurmond Lake, South 
Carolina.  Unusual vacuolization is present (arrow).    
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Table 11.  Presence of hippocampal lesions in mice exposed to extracts of 
Hydrilla verticillata and associated epiphytes collected from Potato Creek 
Embayment, South Carolina and Parksville Cove, J. Strom Thurmond Lake, 
South Carolina. 
 
Experimental Group Presence of lesions 
Potato Creek Crude 
Parksville Crude 
Particulates 
Hexanes 
Methylene Chloride 
Aqueous Methanol 
 
0/3 
2/3 
3/3 
3/3 
1/4 
1/3 
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Figure 24.  Cell cycle distribution of C6 cells after exposure to four fractions 
produced from the AVM-positive crude extract at 100, 50 and 12.5 mg/ml.  Data 
represent means ± SEM from three independent experiments.  Asterisks represent 
significant difference from control with a p-value c 0.05.
100 mg/ml 
50 mg/ml 
12.5 mg/ml 
* *
* *
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Discussion
The goal of this study was to evaluate mammalian susceptibility to AVM 
by administering a known AVM-positive vegetative extract to mice.  Following 
two weeks of exposure to the extract at a dosage which induced AVM in 
mallards, no mice contained white matter lesions consistent with vacuolar 
myelinopathy.  Therefore it appears that mice are not susceptible to the causative 
agent of AVM at concentrations which induced moderately severe lesions in 
birds.  These results agree with previous studies of mammalian susceptibility 
which found no lesion formation in mice and swine following exposure to AVM-
positive vegetation and coot tissues (Lewis-Weis et al., 2004; Rocke et al., 2005; 
Birrenkott, unpubl. data).   
 While the mice did not develop characteristic AVM lesions in this study, 
ten of nineteen mice exposed to either the crude AVM-positive extract or the 
fractions produced from this extract developed unusual lesions localized to the 
hippocampus.  These lesions may have been an artifact of the fixative process, 
although this conclusion is hard to fully accept due to the absence of lesions in the 
control mice.   However, it is also unlikely that if the lesions are real they would 
be induced by all four fractions produced from the crude extract.   The 
fractionation procedure produced four fractions of widely varying polarity, with 
the extremely non-polar hexanes fraction and the extremely polar particulate 
fraction (which was only soluble in water and not methanol), as well as both 
intermediate fractions, resulting in hippocampal lesion formation.   
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 The fractionation procedure did isolate the in vitro toxicity associated with 
the extracts, as the MeCl2 fraction induced a significant increase of cells in G2/M 
following a 4 h exposure.  These results are consistent with those in Chapter 4 
(Wiley, 2007), in which the MeCl2 fraction produced from vegetation collected 
from Woodlake, North Carolina during an AVM epizootic induced a significant 
cell cycle arrest.  The Woodlake fractions were also tested by an in vivo chicken 
bioassay to confirm toxicity, but histological brain analyses for that experiment 
were inconclusive.  Since the mice in the present study also did not develop 
characteristic AVM lesions, it is not known whether the observed in vitro effects 
in these studies are due to the AVM toxin or some other bioactive compound 
associated with the extracts.  
Despite the fact that mice in this study did not develop characteristic AVM 
lesions, there is still a possibility that mammals could be affected by the causative 
agent but are less sensitive than birds.  The extract dosage used in this study was 
based on that which produced lesions in mallards.  The archived extract from the 
mallard study was only sufficient to administer this dosage to the mice for two 
weeks. It was thought that this time period would be sufficient, as several studies 
have now shown that the onset of disease can occur within a two week time 
period (Rocke et al., 2002; Wiley, 2007, Chapter 2, Chapter 3).  However, the 
dynamics of lesion onset are not yet understood, and it is possible that an acute 
exposure could produce lesions if toxin concentrations are sufficient, but also that 
lower concentrations given over a longer time period may also result in AVM.  
Therefore, it is possible that a higher concentration of the extract or a longer 
150 
exposure period would have resulted in AVM lesion formation.  It is also possible 
that while acute exposure to the AVM toxin may not result in the same pathology 
in mammals as in birds, chronic exposure to the toxin may prove to be harmful in 
some way.   
While this study provides a better indication of mammalian susceptibility 
to AVM than previous studies, it is not conclusive evidence that mammals are not 
affected by the causative agent of AVM.  Further study is needed to fully evaluate 
the toxic potential of this disease for mammalian wildlife and humans. The 
development of an extraction procedure for the toxin and work towards further 
isolation of the toxin in crude extracts will provide tools for future research.  If a 
cleaner extract can be developed it could be administered to a mammalian model 
by various routes (intravenous, intraperitoneal, and/or oral) at a wide range of 
concentrations.  It would also be wise to test the extract in acute and chronic 
experiments and examine effects on various parameters in addition to lesion 
formation, including full behavioral evaluations while the animals are live, as well 
as histological evaluation of other tissues and biochemical analysis on blood 
samples.  Increasing the sample size per group beyond three animals and 
processing the brain tissue by a different method would also be helpful in 
evaluating the hippocampal lesions seen in this study.   
The potential for this disease to impact mammalian wildlife and human 
health is evident.  Mammals such as raccoons and foxes have been documented as 
consuming American coots (Fischer et al., 2006), and other herbivorous mammals 
such as beavers are exposed through their diet.  Humans consume waterfowl that 
151 
are known to be affected by AVM, and the potential exposure is increased by the 
fact that hunting season corresponds with AVM epizootics.  While the evidence 
so far suggests that mammals are not susceptible to this disease, further study is 
needed to more fully evaluate the potential effects of the AVM agent on these 
species. 
 
Literature Cited
Birrenkott, A. H., S. B Wilde, J. J. Hains, J. R. Fischer, T. M. Murphy, C. P.  
 Hope, P. G. Parnell, and W. W. Bowerman. 2004. Establishing a food-chain  
 link between aquatic plant material and avian vacuolar myelinopathy in  
 mallards (Anas platyrhynchos). J. Wildlife Dis. 40: 485-492. 
 
Fischer, J. R., L. A. Lewis-Weis, and C. M. Tate. 2003. Experimental vacuolar  
 myelinopathy in red-tailed hawks. J. Wildlife Dis. 39: 400-406. 
 
Fischer, J. R., L. A. Lewis-Weis, C. M. Tate, J. K. Gaydos, R. W. Gerhold, and R.  
 H. Poppenga. 2006. Avian vacuolar myelinopathy outbreaks at a southeastern  
 reservoir. J. Wildlife Dis. 42: 501-510. 
 
Larsen, R. S., F. B. Nutter, T. Augspurger, T. E. Rocke, L. Tomlinson, N. J. 
Thomas, and M. K. Stoskopf. 2002. Clinical features of avian vacuolar  
myelinopathy in American coots. J. Am. Vet. Med. Assoc. 221: 80-85.  
 
Lewis-Weis, L. A., R. W. Gerhold, and J. R. Fischer. 2004. Attempts to reproduce  
vacuolar myelinopathy in domestic swine and chickens. J. Wildlife Dis. 40: 
476-484. 
 
Rocke, T. E., N. J. Thomas, C. U. Meteyer, C. F. Quist, J. R. Fischer, T.  
 Augspurger, and S. E. Ward. 2005. Attempts to identify the source of avian  
 vacuolar myelinopathy for waterbirds. J. Wildlife Dis. 41: 163-170. 
 
Thomas, N. J., C. U. Meteyer, and L. Sileo. 1998. Epizootic vacuolar  
 myelinopathy of the central nervous system of bald eagles (Haliaeetus  
 leucocephalus) and American coots (Fulica americana).  Vet. Pathol. 35: 479- 
 487.  
 
152 
Wilde, S. B., T. M. Murphy, C. P. Hope, S. K. Habrun, J. Kempton, A. Birrenkott,  
 F. Wiley, W. W. Bowerman, and A. J. Lewitus. 2005.  Avian vacuolar  
 myelinopathy linked to exotic aquatic plants and a novel cyanobacterial 
species. Environ. Toxicol. 20: 348-353. 
 
Wiley, F. E. 2007. Extraction method development and in vivo and in vitro 
toxicity studies of the etiologic agent of avian vacuolar myelinopathy. PhD  
Disseration, Clemson University, Clemson, South Carolina. 
 
CONCLUSIONS 
 
The major objectives of this dissertation were to develop extraction 
methods for isolating the AVM toxin from vegetative samples and to develop an 
in vitro, cell-based bioassay for detection and study of the toxin.  The AVM toxin 
was successfully extracted from vegetative samples and methanol was shown to 
be a suitable solvent for this procedure.  The AVM toxin is probably moderately 
polar and water-soluble.  It is stable at -20°C for at least one year and is not 
extremely volatile.  Further fractionation of the crude extract will be necessary to 
provide a more accurate and detailed description of the physical properties.  I 
attempted to further fractionate the crude extract, but unfortunately the presence 
of the AVM toxin in those fractions could not be confirmed due to inconclusive 
results from the in vivo bioassays.   
In vitro toxicity associated with the extracts for AVM-positive sites 
revealed that the toxin may arrest the cell cycle of C6 glioma cells and this effect 
may be an efficient measure of detecting the AVM toxin in environmental 
samples.  However, this effect cannot yet be attributed to the AVM toxin, as the 
extracts tested were in crude form and may have contained other bioactive 
substances.   The toxic activity associated with cell cycle arrest was further 
isolated by fractionation of the crude extracts, but could not be confirmed as the 
AVM toxin due to the inconclusive in vivo results.   
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In vivo bioassays remain the only method of confirming the AVM toxin in 
environmental samples.  The cell cycle assay may provide a suitable in vitro assay 
for toxin detection, but it must first be validated through the use of parallel in vivo 
studies.  The challenges that occur with in vivo studies, including the choice of an 
appropriate animal model and time period of exposure, must be resolved before a 
successful in vitro method can be confirmed.  Mallards appear to be the most 
reliable model, but require an extensive amount of sample material to conduct the 
assays and are also difficult to acquire.  Chickens are more readily available, and 
young chicks require much less sample material, but it is unclear whether they are 
as susceptible to the AVM agent as mallards.  A parallel study using both 
mallards and chicks would be useful in determining the susceptibility differences 
of these species.  The time period of exposure necessary to induce toxicity is also 
still unknown, but it is recommended that subsequent in vivo assays include at 
least a four-week exposure period until this variable is more fully understood.   
The presence of AVM-affected birds on a reservoir is not sufficient 
evidence that the AVM toxin will be present in collected vegetation.  Therefore, 
vegetation collected for future toxin isolation procedures should be tested by an in 
vivo bioassay to confirm AVM toxin presence prior to conducting toxin 
extraction.  While this will add an extra step in the research process, it will 
prevent the waste of time and resources in preparing extracts of vegetation that 
may not be toxic.  It is also recommended that vegetation be collected as soon as 
AVM-affected birds are documented on the reservoirs to have a better chance of 
collecting material containing the active toxin. 
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The issue of mammalian susceptibility is not fully resolved.  Mice exposed 
to the AVM toxin by gavage in this research did not develop characteristic AVM 
lesions, providing further evidence that mammals are not susceptible.  However, 
unusual hippocampal lesions were present in several mice exposed to these 
extracts.  While these lesions may be artifactual, additional experiments are 
needed to further evaluate a possible causative link between the AVM toxin and 
the presence of these lesions.   
AVM continues to impact eagle and coot populations in the Southeast.  
Management and mitigation of AVM depends upon continued research efforts 
towards identifying the source of this disease.  The extraction methods developed 
here, as well as the preliminary work at identifying an in vitro model for AVM, 
will greatly benefit the continued search for the causative agent.  Further efforts at 
isolating the toxic agent and validating the in vitro assay are needed to continue 
this valuable line of research.   
 
